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Peter Klijn 
Cystic Fibrosis
Incidence and mortality 
Cystic fibrosis (CF) is the most common life-shortening genetic disease in the
Caucasian population. It is inherited as an autosomal recessive disease. CF has
an incidence of 1 in every 2500 Caucasians life births, 1 in 17000 blacks and 1 in
90000 Orientals [1].
The first accurate description of CF was published in 1938 when more
than 80% of CF patients died within 1 year of birth [2].  Since then, our under-
standing of the basic pathophysiologal mechanisms and significant improve-
ments in diagnosis and treatment have increased. These developments
improved prognosis and median survival age from 18 yr. in 1976 to 29 yr. in the
early 1990s [1].  Recent estimates have projected a median survival of 40 years
for children born in 1990 who are receiving current standard therapy for CF [3,4].
With further progress, the outlook may even be more optimistic. Frederiksen and
colleagues stated that the survival probability for a CF child born after 1989 to
reach his or hers 45th birthday was 80.4% (95% confidence interval 76.5-84.6%) [5].
Pathogenesis and diagnosis.
A range of different mutations at the DNA level can cause CF. The most com-
mon CF gene mutation [∆F508] is the absence of three sequential nucleotides
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(one cytosine, two thymines), which leads to the deletion [∆] of a phenylaline
residue (F) at partition 508 on the cystic fibrosis transmenbrane conductance
regulator (CFTR) [6].  CFTR is important in the flow of electrolytes and fluid
across cellular membranes. The resultant of the basic defect is sweat that is high
in sodium and chloride levels, and mucus that is abnormally thick and vicous [7].
In the lungs this leads to impaired mucocilliary clearance, infection with bacte-
ria, and inflammatory response, and ultimately to fibrosis, and progressive lung
destruction [8] (figure 1). Loss of functional lung tissue leads to respiratory com-
promise and is responsible for more than 90% of the morbidity and mortali-
ty in CF [9].
Mucus and inflammation in the pancreas and gastrointestinal tract
result in insufficient secretion of digestive enzymes and malabsorption of nutri-
ents [10]. Nutritional deficiencies lead to decreased fat stores and, as a result of
protein malnutrition, may even lead to muscle wasting [11,12]. Pancreas insuffi-
ciency occurs in 90% of patients with CF [11,12].
Recent advances in CF genetics have major implications for earlier and
more accurate diagnosis of the disease and for identification of CF gene carriers
(genotyping).  At present, CF is clinically diagnosed with the classic ‘diagnostic
triad’: abnormal sweat chloride concentration (> 60mEq/L), chronic pulmonary
disease, pancreatic insufficiency [1]. Pulmonary disease and/or pancreatic insuf-
ficiency may be clinically inapparent early in life. 
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defective CF Gene
defective CFTR
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bronchiectasis
Figure 1 
Pathophysiologic cascade for CF pulmonairy disease from Davis [1]
Pathophysiology
Patients with CF differ greatly in the expression of pulmonary symptoms, but the
natural history of the disease shows progressive lung disease during life. In ge-
neral, early impairment in lung function results primarily from obstruction and
inflammation of the small airways by obstructive viscous secretions, leading to
increased airway resistance and hyperinflation with increased residual volume
(RV) [13,14]. These events are accompanied by a decrease in maximal midexpi-
ratory flow (FEF25-75%), followed by reductions in forced expiratory volume in one
second (FEV1) and forced vital capacity (FVC). Progressive peripheral bronchial
obstruction, leads to a mismatch of ventilation/perfusion, a decreased oxygena-
tion, and an impaired gas exchange. 
Current treatment strategies are generally aimed at control of pul-
monary infection through antibiotic treatments, improvement of mucociliary
clearance with chest physiotherapy and nebulisation, and improvement of nutri-
tional status through hyperalimentation and enzyme replacement. In addition,
physical activity is an essential element in the care for patients with CF and
patients should be encouraged to exercise regularly.
Exercise and cystic fibrosis
The benefits of exercise in CF have been recognized as early as in1969 [15].
Survival and favorable prognosis in patients with CF have been associated with
higher aerobic fitness and better nutritional status [16-18]. Important determi-
nants of aerobic exercise performance are pulmonary function and nutritional
status [12,13,19-22].
The majority of scientific research in patients with CF has focussed on
aerobic exercise capacity. With aerobic training, skeletal muscle undergoes struc-
tural and biochemical changes, which permits a greater extraction and more effi-
cient usage of oxygen delivered by the cardiorespiratory system. The ability to
sustain exercise comfortably, or in other words exercise tolerance, is thought to
influence the degree of daily activities and the feeling of well-being in everyday
life [23-25].
The role of exercise training in the treatment of CF has received increas-
ing attention over the past 15 to 20 years. Table 1 summarizes published exercise
studies that included children with CF. All studies used an aerobic training pro-
gram, while one study used resistance-training [26]. These studies will be briefly
discussed with respect to pulmonary function, functional status and quality of
life. However, a remark should be made on the methodological quality of some
of these studies, since they did not use a control group [27-29] or randomized
design [30-35]. Only three studies used a randomized controlled design
[26,36,37].
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After aerobic training, a significant increase in exercise tolerance was found in
several controlled [30-35] and randomized controlled [26] trials, whereas uncon-
trolled studies [27,28] did not find improvements in exercise capacity.
Schneiderman-Walker and colleagues reported no aerobic training effect after a
three-year unsupervised home exercise program [37]. This raises the question if
unsupervised programs are effective in improving aerobic capacity.
The only published resistance-training study in children with CF, report-
ed significant larger improvements in leg muscle-strength in the resistance-
training group than either the aerobic training group or the control group [26].
With respect to pulmonary function, significant improvements were
found in several short-term studies after aerobic training [27,29], while in other
studies [30,31] these positive effects were not seen. Changes in pulmonary func-
tion were reported in two randomized controlled studies [26,37]. Schneiderman
and coworkers reported a significant greater mean rate of annual decrease in
FVC percentage predicted in the control group compared to the exercise group
at three year follow-up [37]. The resistance-training group in a study by Selvadurai
and colleagues showed greater mean increase in FEV1 percentage predicted
compared to the aerobic training group or the control group [26].
Improvement in quality of life after aerobic training, as measured with
perceived competence scales or generic questionnaires, was reported in three
studies [26,32,37]. Disease-specific questionnaires are thought to be more sen-
sitive for specific problems associated with CF than generic questionnaires [38].
Measures of health-related quality of life (HRQL) are multidimensional
constructs that include the core dimensions of physical, psychological, social
and occupational functioning [38]. HRQL summarizes the subjective judge-
ments patients make to describe their experiences of health and illness.
Traditional clinical measures do not capture the impact of the disease on physi-
cal, social and psychological functioning [38-40]. Thus, HRQL measures can
make a significant contribution to a comprehensive assessment of functioning
in CF. In addition, HRQL measures are useful in detecting transient changes in
health status or functioning due to an intervention (e.g. drug therapy, exercise
training, psychosocial).
Therefor, a reliable and valid CF-specific health-related measure was
developed: the Cystic Fibrosis Questionnaire (CFQ) [41,42]. However, a Dutch
disease-specific questionnaire is not yet available. Cross-validation of the CFQ
will be an important part of this thesis.
In summary, with short-term aerobic training children with CF are able
to improve their aerobic fitness but not their pulmonary status. However, long-
term participation in exercise programs seems important in slowing the decline
in pulmonary function, which ultimately may improve prognosis. Moreover,
resistance-training seems to be of clinical value next to aerobic training.
Gulmans and colleagues showed that acceptability of single activity programs is
very poor [32]. In order to increase long-term compliance to exercise, programs
should consist of a variety of activities, which are enjoyable for the participants.
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Simultaneously, exercise should be beneficial in terms of health status, func-
tional status and quality of life, since it is included into the already demanding
regimen of (daily) care of patients with CF.
In the next part, a framework will be presented to incorporate anaerobic
activities in exercise programs for children with CF.
Concept of anaerobic training
Aerobic and anaerobic energy metabolism
During any muscular work, anaerobic and aerobic metabolism is inextricably
linked [43]. The relative contribution of both systems depends on the preferen-
tial use of the systems (e.g. type of training). Within the first seconds of muscle
contraction, the anaerobic alactic pathway provides a high level of mechanical
output at a very fast rate through the split of creatine phosphate (PCr) and
adenosine triphosphate (ATP) stored in the resting muscle cells [44]. The capac-
ity of this pathway is limited in humans. It has been calculated that this energy
reserve is almost totally depleted after about 25 seconds of maximal exercise
[45,46]. The next pathway, the anaerobic glycolysis, generates lactate. Its maxi-
mal rate of energy supply is only about half that of the ATP-PCr pathway, but its
capacity is twice as great [44]. The aerobic pathway demonstrates the slowest
rate of energy supply, but its capacity is immense, allowing exercise for hours at
submaximal levels. 
Figure 2 
Total and relative energy production: Adenosine triphosphate (ATP) resynthesis (see text for explanation)
Figure 3 
Characterization of physical activity in Children. From Bailey [49]
It is important to understand that all three pathways operate at the same time
even in short-term exercise lasting for a few seconds. Moreover, energy pathways
are not recruited in a mutually exclusive sequence, but a particular energy source
may dominate during a certain phase without exclusion of the other energy path-
ways [44].
Characterization of pediatric physical activity
Assessment of physical activity has become increasingly important with the
growing awareness of the association between physical activity, health, growth
and development. 
Many techniques to assess habitual physical activity have been devel-
oped and the advantages and disadvantages have been extensively reviewed
[47,48]. Direct observational methods are especially useful in order to make an
accurate characterization and quantification of energy expenditure. Bailey and
coworkers used this method to capture the patterning of activities by frequency,
duration and intensity [49]. They showed that the pattern of children’s physical
activity under free living conditions could be characterized as ‘short bursts of
vigorous physical activity interspersed with varying intervals of low and moder-
ate intensity’. The median duration of low and medium intensity activities being
6 seconds, and of high intensity activities only 3 seconds with 95% lasting less
than 15 seconds (figure 3). This implies that children’s physical activity pattern is
predominately anaerobic in nature. 
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Habitual physical activity
Despite the proven benefits of aerobic exercise, the evidence of relating habitu-
al physical activity to children’s aerobic capacity is not strong [50].  The periods
of habitual activity may not be sustained for periods of sufficient length associ-
ated with a cardiovascular training response [51]. In children with CF as well as
in healthy children, levels of activity tend to decrease in the mid to late adoles-
cence [52]. In addition, it has been shown that the amount of daily physical activ-
ity is clinically related to a diminished nutritional status in children with CF with
significant airflow limitation [53].
Daily activities as well as sporting activities frequently require repeated
bouts of intense anaerobic exercise – for example climbing a flight of stairs,
short sprints to catch a bus, playing football or basketball, playing chase on the
school play ground – rather than performance of sustained, aerobic efforts. In
children with CF, less time spend in vigorous physical activities is associated
with lower aerobic fitness, despite a good pulmonary function [54]. Data on the
relationship between daily physical activity and anaerobic fitness in children are
lacking.
CF and anaerobic exercise 
In some pediatric diseases, anaerobic muscle power and muscle endurance is
deficient. In CF, malnutrition may influence muscle performance and decrease
anaerobic exercise capacity. However, data are limited regarding anaerobic per-
formance in children with CF. Only four studies have compared anaerobic per-
formance in children with CF with healthy children. In all studies anaerobic per-
formance was related to some measure of nutritional status, percentage of ideal
body weight [55], body mass index [11], lean body mass [56] and fat-free mass [57].
With respect to pulmonary function, only Cabrera and colleagues reported an
association between anaerobic performance and increased severity of lung dis-
ease [55]. The other three studies concluded that anaerobic performance was not
related to pulmonary function [11,56,57].
Boas and colleagues reported a marked increase in glycolytic energy
contributions during an anaerobic exercise test in children with CF, which was
related to reduced pulmonary function or aerobic capacity [57]. They suggested
a compensatory increase in ATP-phosphocreatine or glycolytic pathways (in a
disorder associated with chronic hypoxia). This was also suggested in a study in
children with asthma [58]. Counil and colleagues observed an altered maximal
anaerobic power in children with asthma, which might have originated from
qualitative modifications in anaerobic metabolic pathways [58].
In summary, it would appear that the transitory nature of children’s
physical activity patterns might be well suited for a high intensity intermittent
training program. Short, high intensive activities simulate conditions that repli-
cate many daily activities as well as play and sport activities. Since children with
9
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CF have lower anaerobic capacity and do not participate as much in high inten-
sity activities as their healthy peers, anaerobic training may not only improve
anaerobic exercise performance but also health-related quality of life. In addition,
anaerobic training may support the proposed physiological adaptation process
seen in CF due to chronic pulmonary disease.
Scope and outline of this thesis 
Our primary aim was to develop an anaerobic training program for children with
CF, and to investigate the effects of this program on several components of
physical fitness, pulmonary function, nutritional status and health-related quali-
ty of life. Incorporating anaerobic activities in exercise programs contributes to
greater variation of exercise and are thought to increase adherence and accept-
ability of exercise in treatment of CF.
As shown in the introduction, in cross-sectional studies aerobic capaci-
ty is related to the severity of pulmonary function and nutritional status. In chap-
ter 2 the longitudinal relationship between aerobic performance, lung function
and nutritional status in children with CF is described. Since little is known about
the anaerobic performance in children with CF, chapter 3 describes the determi-
nants of anaerobic exercise performance, with special reference to disease sever-
ity. Chapter 4 describes the process of validation of the Dutch version of the
Cystic Fibrosis Questionnaire, for school age children (CFQ-C) and their pa-
rents (CFQ-P). In chapter 5 the validation of the Dutch version of the Cystic
Fibrosis Questionnaire for adolescents and adults (CFQ-14+) is described. The
effects of our anaerobic training program on aerobic and anaerobic exercise per-
formance, pulmonary function, body composition, peripheral muscle strength
and health-related quality of life (HRQL) of children with CF are provided in
chapter 6. Chapter 7 contains a general discussion and suggestions for further
research.
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Abstract
Background: Several cross-sectional studies in patients with cystic fibrosis (CF)
have shown that nutritional status and lung function are important determinants
of peak aerobic capacity (VO2peak). In order to account for individual changes
the aim of this study was to determine the longitudinal relationship of changes
in nutritional status, lung function and VO2peak in children with CF. 
Design and methods: Fat-free mass (FFM), lung function and VO2peak
were assessed in sixty-five children with CF at baseline (age 10.5 ± 2.9 year and
FEV1 92.6 ± 20.5%) and again two years later. FFM was calculated using skin fold
thickness and VO2peak was measured using an incremental treadmill test for
children until the age of 12 or an incremental cycle ergometry test for children of
12 years and older. Lung function was measured before the exercise test.
Results: Over the two-year study period an increase was found for
absolute values of FFM (6.1 kg, p<0.001), forced expiratory volume in one se-
cond (FEV1: 229 ml, p<0.001) and VO2peak (240 ml, p<0.001), while a decrease
was found for predicted values of FEV1 (–8.9%, p<0.001) and VO2peak (–4.4%,
p<0.05). Changes in VO2peak (dVO2) over the two-year period were best corre-
lated with changes in FEV1 (dFEV1; r=0.619, p<0.001) and to a lesser degree with
the changes in FFM (dFFM; r=0.506, p<0.001). Multiple regression analysis
demonstrated that dFEV1 and dFFM explained 47% of the variation of the
change in VO2peak over the two-year period. 
15
Conclusions: Our results show that longitudinal changes in VO2peak are asso
ciated with changes in lung function and to a lesser extent with changes in nutri-
tional status in children with CF. Special consideration should be given to exer-
cise training and nutritional intervention which might improve long-term clinical
outcome in children with CF.
Introduction
Cystic Fibrosis (CF) is characterized by deterioration of nutritional status and
irreversible loss of lung function. Favorable prognosis and survival in this patient
group have been associated with higher aerobic fitness and better nutritional
status while mortality of most patients is determined by the rate of deterioration
of respiratory function [1,2]. Several cross-sectional studies have shown that
aero-bic performance in patients with CF is associated with nutritional status [3-
6]. In these studies, patients with a diminished body weight have a lower aero-
bic capacity compared to age-matched healthy controls. Furthermore, CF has
adverse effects on fat mass and fat-free mass (FFM). Nutritional deficiencies
may lead to decreased fat stores and, as a result of protein malnutrition, may
even lead to muscle wasting [4,7]. Muscle mass, which is the largest constituent
of fat-free mass (FFM), is found to be a critical determinant of peak aerobic per-
formance [8,9]. 
Another major determinant of aerobic capacity is the lung’s ability to
exchange gas [10]. Cross-sectional sectional data in patients with CF show that
poor lung function is associated with reduced aerobic performance [11,12]. 
From cross-sectional studies it can be speculated that individual
changes in aerobic performance are caused by changes in lung function and
nutritional status. However, with cross-sectional sectional investigations indi-
vidual changes cannot be detected. Longitudinal data may enable clinicians to
design interventions that are relevant and effective in improving outcome in chil-
dren with CF. The longitudinal relationship between aerobic performance, lung
function and nutritional status has been described for adults with CF [13] but has
not been studied previously in children with CF. The aim of this study was to
determine the longitudinal relationship between changes in aerobic perform-
ance, lung function and body composition in children with CF.
Methods
Subjects
Measurement of nutritional status, lung function and exercise performance is
part of the annual medical check-up of the Cystic Fibrosis Center of the
Wilhelmina Children’s Hospital and University Medical Center at Utrecht.
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Patients who met the following criteria were approached for the study: age
between 4 and 18 years, stable clinical condition, i.e. no need for oral or intra-
venous antibiotic treatment in three months prior to testing and the children
should be able to perform the tests. One hundred and sixty three children with
CF were eligible for inclusion in the study. Seventy-nine children and their pa-
rents agreed to participate. Children completed the measurements of nutritio-
nal status, lung function and exercise performance (T1) and again two years later
(T2). The treatment regime for the study subjects was consistent with current
standards of care for CF. The study was approved by the institutional review
board. Assent was obtained from each participant and informed consent from
their parents.
Lung function testing
Forced vital capacity (FVC) and forced expiratory volume in one second (FEV1)
were obtained from maximal expiratory flow-volume curves (Masterscreen;
Jaeger, Wuerzburg, Germany). Values are expressed as the percentage of pre-
dicted values [14].
Assessment of nutritional status
Weight and height were measured with an electronic scale (Mettler, Greifensee,
Switzerland) and a stadiometer (Holtain, Crymich, UK), respectively. Body mass
index (BMI) was calculated from the ratio weight/height2 (kg/m2). Left-sided
biceps, triceps, subscapular and supra iliac skinfolds were measured with an
accuracy of 0,1 mm (Holtain caliper, Crymich, UK). The mean of three readings
was recorded for each site. Total body fat percentage was estimated by the use
of age- and gender-dependent equations on the relation between body fat per-
centage and body density [15]. FFM was then calculated as the difference
between body weight and fat mass (FM). 
Exercise testing
The standard exercise protocol for annual check-up measurements was used.
Until the age of 12 years, the children performed a treadmill test according to the
Bruce protocol [16]. Children aged 12 years and older used an electronically
braked cycle ergometer (Lode Examiner; Lode, Groningen, The Netherlands).
Workload increased 15 W each minute. Subjects were asked to maintain a ped-
aling rate at 60 rpm. During the tests patients were encouraged to perform to
the best of their abilities. Both tests were continued to voluntary exhaustion. 
Continuous respiratory gas analysis and volume measurements were
performed breath-by-breath with a triple V valveless mouthpiece and stored in a
computerized exercise system (Oxycon Champion, Jaeger, Breda, The
Netherlands). Measurements taken included oxygen uptake (VO2), carbon
2
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dioxide production (VCO2), ventilation (VE) and respiratory exchange ratio
(RER). The highest VO2 achieved during the last 30 seconds of exercise was
taken as VO2peak [17]. Heart rate was monitored by 3-lead electrocardiogram
(Hewlett-Packard, Amstelveen, The Netherlands) and oxygen saturation (SpO2)
by pulse oximetry (Nellcor 200 E, Breda, The Netherlands). Internal gas and vol-
ume calibrations were made before each test.
Efforts were considered to be at a maximum level if subjects showed
clinical signs of intense effort and were unable to maintain speed [18], and if at
least one out of two criteria were met: 1) cardiac frequency above 180 beats/min;
2) maximal respiratory exchange ratio (i.e. VCO2/VO2) above 1.0 [5,10].
Predicted VO2peak (VO2peak%) values were obtained from an age and
gender matched Dutch reference population, which used the same modes of
exercise [19].
Data analysis
Data are presented as mean value ± standard deviation unless otherwise indi-
cated. Comparisons of group characteristics between T1 and T2 were made with
paired t tests. Individual differences in FFM (dFFM), FEV1 (dFEV1) and VO2peak
(dVO2peak) were calculated between T1 and T2 (T12).  Correlation analyses
(Pearson’s r) and stepwise linear regression were made for dFFM, dFEV1 and
dVO2peak for the two measurements. Differences were considered significant if
p < 0.05 (two-tailed). Data were analyzed using the Statistical Package for the
Social Science (SPSS, version 9.0, Chicago. IL, USA).
Results
Eight out of the 79 children were excluded from the analysis because they did not
fulfill the criteria for a maximum exercise test. Six children reached the age of
twelve during the study period and therefore changed from treadmill to cycle
ergometer. Several studies have shown higher VO2peak on a treadmill compared
to a cycle ergometer [20-22]. Consecutive annual changes in VO2peak could be
the result of different exercise modes and therefore these six children were also
excluded. 
Table 1 summarizes the characteristics of the study group at T1 and T2
( N=65). The group had mild to moderate airflow obstruction while their ages
were normally distributed. There were no differences between the patients that
collaborated in the study and the group of CF patients (N=163) that was eligible
for participation. Comparisons between boys and girls showed no differences in
baseline characteristics or in changes of the study parameters during the study
period.
18
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Table 1 Patient characteristics at baseline and at repeat testing two years later
Subjects (n=65) T1 T2
Age, yr 10.5 (2.9) 12.5 (2.9)
Body weight, kg 33.6 (11.3) 40.6 (12.7)
Height, cm 140.8 (17.0) 151.6 (16.4)
BMI, kg/m2 16.5 (2.0) 17.2 (2.5)
FFM, kg 27.6 (9.3) 33.6 (10.4)
FEV1, ml 1828 (630) 2055 (713)
FEV1, % pred 92.6 (20.5) 83.6 (21.5)
FVC, ml 2260 (732) 2694 (828)
FVC , % pred 94,8 (15,4) 92.3 (14.9)
VO2peak, ml/min 1435 (475) 1678 (524)
VO2peak, %pred 91.4 (21.7) 87.1 (20.3)
Values are mean ± SD. BMI = body mass index; FFM = fat free mass; 
FEV1 = forced expiratory volume in one second; FVC = forced vital capacity; 
VO2peak = peak oxygen uptake.
Tabel 2 Comparisons of differences between means for fat-free mass, 
lung function and aerobic capacity
T12
FFM (kg) 6.1  (5.3 to 6.9) ‡
FEV1 (ml) 229 (134 to 325) ‡
FEV1, % pred -8.9 (-12.8 to -4.8) ‡
VO2peak (ml/min) 240 (162 to 318) ‡
VO2peak % pred -4.4 (-8.52 to -0.29) *
FFM = fat free mass; FEV1 = forced expiratory volume in one second; 
VO2peak = peak oxygen uptake. * p<0.05; †  p<0.01; ‡  p<0.001
Tabel 3 Correlation between changes in body composition, 
lung function and peak aerobic capacity over two-year period
dFEV1 dVO2peak
dFFM 0.506‡ 0.564‡
dFEV1 0.619‡
dFFM = change in fat free mass; dFEV1 = change in forced expiratory volume in one second; 
dVO2 = change in peak oxygen uptake. †  p<0.01; ‡  p<0.001
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Figure 1 
The individual change in peak oxygen uptake (VO2peak) related to 
A) the change in fat-free mass (FFM) [r = 0.564; p < 0.001] and B) the change in forced expiratory volume
in one-second (FEV1) [r = 0.619; p < 0.001] over a two-year period (T12).
Comparisons between T1 and T2 are presented in table 2. Absolute values of
FFM, FEV1 and VO2peak increased during the two-year period. With respect to
predicted values, FEV1% and VO2peak% decreased over the two-year period.
Correlations between individual changes in body composition, lung function
and aerobic performance are shown in table 3. The changes in VO2peak corre-
lated best with changes in FEV1 and to a lesser degree with changes in FFM.
The relationship between these variables and dVO2peak for T12 are demonstrat-
ed in figure 1.
Changes in FEV1, FFM, height, weight and BMI were entered in a step-
wise regression model, with dVO2peak as the dependent variable. Analysis
revealed that dFEV1 (p<0.001) explained 38% of the variation in dVO2peak. dFFM
(p<0.001) was also included in the model, whereas changes in height, weight
and BMI were excluded. Together dFEV1 and dFFM accounted for 47% of the
variability in dVO2peak (regression equation: dVO2peak = -60.4 + 0.40 · dFEV1 +
33.40 · dFFM).
Discussion
We longitudinally studied the effect of changes in FFM and lung function on
peak aerobic capacity in children with CF. Our longitudinal data indicate that
changes of peak aerobic capacity in children with CF can be ascribed, to a great
extent, to changes in lung function. The additional effect of changes in FFM may
increase up to 9% of the explained variance of the changes in VO2peak. 
The results of this longitudinal study are in agreement with results from
cross-sectional sectional studies showing that lung function [3,4,6,23,24] and
nutritional status [3,4,6] are important predictors of aerobic performance in
patients with CF. Long-term data describing the relationship between these vari-
ables in children are not available. Moorcroft and colleagues reported a decline
in absolute and predicted values of FEV1 in adult patients with CF over a mean
period of 6.3 years [13]. VO2peak remained stable in this study and an association
between lung function and aerobic capacity was not found. In our study, the
increase in absolute VO2peak was mainly related to an increase in FEV1. Lung
growth typically occurs in healthy subjects under the age of 20 years and may
account for the increase in FEV1 [25]. In young patients with CF the growth-relat-
ed increase in absolute values of FEV1 might compensate for the disease-related
loss of pulmonary function.  In addition, the amount of FFM seems a potential
factor in offsetting losses in pulmonary function [13]. In the study of Moorcroft
and coworkers potential lung growth was not to be expected. This could explain
the absence of an association between change in lung function and aerobic
capacity in their study. Our patients clinically deteriorated over the two-year peri-
od as FEV1 (% of predicted) decreased, which is in agreement with the study
results of Moorcroft and colleagues [13]. However, in addition we found a con-
comitant decrease in age- and gender predicted values of VO2peak. Absolute
2
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values of lung function show lung growth in children with CF but may underes-
timate progression of lung disease [13]. The clinical relevance of absolute
changes in FEV1 and VO2peak in young children with CF, can only be judged
when predicted normal values of FEV1 and VO2peak are taken into account.  
FFM is a critical determinant of aerobic exercise capacity in conditions
of health and disease [5,9,26]. Long-term decline in nutritional status with a
reduction in total body weight occurs in many patients with CF. When patients
with CF reach adulthood, the main impact of weight loss is likely a decrease in
FFM since there usually is a preexisting reduced fat mass [26]. FFM increased
significantly during the study period, which was to be expected due to the young
age of our patients. During the normal process of growth, FFM increases but dif-
ferent periods of FFM deposition can be discriminated [27]. Tempo and timing
of progression in VO2peak may depend on age- and gender related changes in
fat-free mass. Since reference values for FFM are not available, it is not clear how
large the increase in muscle mass should be, based on gender and age. In order
to detect clinically relevant changes in FFM of individual patients, more research
is warranted to develop age- and gender specific values for pediatric FFM pro-
portions. 
Measuring FFM by measurement of skinfolds is based on the assump-
tion that measuring fatness reflects lean body mass as well. Besides that, it
assumes that subcutaneous distribution of fat is a constant proportion of total
body fat. Both might be questioned. However, significant correlations between
FFM estimated with skinfold measurements as compared to water isotope dilu-
tion techniques, which is considered to be the gold standard, have been pub-
lished [28]. Furthermore, de Meer and colleagues showed that skinfold meas-
urements can be used to monitor FFM irrespective of clinical severity of CF [29].
Results of cross-sectional sectional studies in chronic airway obstruc-
tion have shown a relationship between lung disease and nutritional status,
which acts by a catabolic intermediary metabolism secondary to pulmonary
infection and inflammation [30,31]. In general, chronic catabolic influence of
inflammatory mediators (cytokines) may induce protein breakdown and inhibit
muscle development in patients with CF [32,33]. To our knowledge there are no
studies available in which the long-term association between lung function and
body composition in children with CF have been described. The relationship
between dFFM and dFEV1 over our study period (r2 =  0.25) is in agreement with
the cross-sectional relationship between lung function and nutritional status
found for children (r2 = 0.06 to 0.25) [34] and adults (r2 = 0.19) [13] with CF.
Other factors, like habitual physical activity, muscle function and periph-
eral muscle strength are also important for maintaining exercise tolerance. A
limitation of our study is that we did not assess daily physical activity. It has been
shown that the amount of daily physical activity is related to a diminished nutri-
tional status [35] and that the amount of time spend in vigorous physical activi-
ties is associated with lower aerobic fitness [36]. In addition, Lands and col-
leagues found that muscle function assessed with an anaerobic exercise test,
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was a more sensitive determinant of maximal aerobic capacity than lean body
mass in adults with CF [3]. In children with CF peripheral muscle force is related
to maximal work load, even in the absence of diminished pulmonary function
and nutritional status [34]
Our results suggest that deterioration in lung function in children with
CF might also point to a significant decrease in peak exercise capacity. The latter
is associated with quality of life [37] and survival [1]. Special consideration should
be given to exercise training, since several studies have shown positive effects
on lung function, VO2peak and quality of life after a period of exercise training [38-
40]. Since FFM has an additional effect on aerobic performance, emphasis
should also be given to nutritional management [13]. 
We conclude that longitudinal changes in lung function are associated
with functional changes in the aerobic capacity of children with CF. On the long-
term, FFM may be important for maintaining functional exercise capacity. We
speculate that regular exercise training and nutritional intervention might effec-
tively improve long-term clinical outcome in patients with CF. 
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Abstract
Anaerobic fitness is important for daily functioning of children with cystic fibrosis
(CF). The aim of this study was to assess the determinants  of anaerobic perform-
ance in CF. Anaerobic performance was measured in thirty-nine children with CF
(mean age 13.2 ± 1.8 [SD] yr, FEV1 81.6 ± 22.1% predicted) using a Wingate anaero-
bic Test. Significant associations were found for peak power (PP) and mean power
(MP) with fat-free mass (FFM) body weight, body mass index, maximal isometric
muscle force and aerobic capacity. Pulmonary function was correlated with anaero-
bic indices when controlled for FFM. Multiple regression analysis indicated that
FFM and FEV1 accounted for 82% and 86% of the variability in PP and MP, respec-
tively. Patients with moderate CF (FEV1 < 80 %), as compared to mild CF (FEV1 ≥
80 %), had higher PP (difference = 85 W [95% CI = 27 to 144 W] and MP (difference
= 53 W [95% CI = 42 to 63 W]) at equivalent FFM. Our results indicate that FFM and
pulmonary function are important determinants of anaerobic exercise performance
in children with CF. With progression of pulmonary disease, anaerobic performance
may be enhanced.
Introduction
Many studies have shown that aerobic fitness is important for well being and prog-
nosis in patients with cystic fibrosis (CF)[1,1,2].  More recently, several authors have
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addressed the important role of anaerobic fitness in daily functioning[3-5].  Many
activities in daily life as well as sport activities have considerable anaerobic compo-
nents [4,6]. Especially in children physical activity patterns are characterized by short
intense activities which predominantly depend on anaerobic characteristics of the
exercising muscle.[7]  Several studies have shown reduced anaerobic performance
in children and adolescents with CF[3-5,8-10] predominantly due to poor nutritional
status.[3-5] In children with CF reduced pulmonary function may lead to hypoxic con-
ditions in exercising muscles and to increase in muscle glycolytic metabolism dur-
ing short-term exercise, both impairing muscle function [3].  Although poor muscle
strength and airflow limitation are related to a decrease of aerobic fitness,[11] the
direct effects of pulmonary function and muscle force on anaerobic performance are
not clear yet.
With respect to the importance for daily functioning, we studied the deter-
minants of anaerobic exercise performance in children with CF. Insight into these
determinants might direct future intervention strategies for improvement of anaer-
obic performance and well being of these patients. 
Methods
Subjects
Thirty-nine children with CF, who were able to perform the study protocol, were
recruited from the CF-Center of the Wilhelmina Children’s Hospital, University
Medical Center Utrecht. Children aged 9-17 year with a stable clinical condition, no
active musculo-skeletal disorders and a forced expiratory volume in 1 sec (FEV1) >
30% predicted were included. Our institutional Ethics Committee approved the
study protocol. Informed consent was obtained from each participant or from his or
her parents.
Nutritional assessment
Anthropometric measurements were made prior to exercise testing. Body weight
was measured using a platform beam balance (Mettler, Greifensee, Switzerland)
with an accuracy of 0,02 kg. Height was measured with a stadiometer (Holtain,
Crymich, UK) with an accuracy of 0,1 cm. Fat-free mass (FFM) was determined in
fasting condition using bioelectrical impedance techniques [3,12]. Body mass index
(BMI) was calculated (weight/height2). 
Peripheral muscle strength
Isometric muscle force measurements were performed for six muscle groups on the
nondominant side of the patient, using a hand-held dynamometer (Penny and
Giles, Christchurch, UK). Measurement of maximal voluntary force of the shoulder
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abductors, elbow flexors, hip-extensors and knee extensors were made, as described
by Bäckman [13]. Each muscle group was tested three times and the highest value
obtained was reported. 
Pulmonary function tests
Pulmonary function tests were performed after administration of 800 µg of  salbu-
tamol, in order to rule out important bronchial hyperreactivity. Forced vital capacity
(FVC) and forced expiratory volume in one second (FEV1) were obtained from max-
imal expiratory flow-volume curves (Masterscreen; Jaeger, Wuerzburg, Germany).
Residual volume (RV) and total lung capacity (TLC) were measured in a volume-
constant body plethysmograph (Masterlab; Jaeger, Wuerzburg, Germany) and the
RV/TLC ratios were calculated from the actual values. Valus are expressed as the
percent of predicted values [14]. 
Exercise testing
Subsequent anaerobic and aerobic exercise tests were performed on an electroni-
cally braked cycle ergometer (Lode Examiner; Lode, Groningen, The Netherlands).
The seat height was adjusted to the patient’s leg length. Each subject performed a
Wingate test (WanT) to assess anaerobic performance. The subjects rested for at
least 45 minutes before aerobic fitness was assessed. During the tests heart rate was
monitored continuously by 3-leads electrocardiogram (Hewlett-Packard,
Amstelveen, The Netherlands) and oxygen saturation (SaO2) by pulse oximetry
(Nellcor 200 E, Breda, The Netherlands). All subjects were familiar with the test
equipment. Verbal encouragement was given throughout the tests to stimulate max-
imal performance.
Anaerobic testing
The WanT consists of a 30-second all-out sprint on a cycle ergometer against a fixed
resistance [15].The WanT is a valid and reliable test to evaluate short-term anaerobic
power in healty children, children with CF and other chronic illnesses [3,9,15-17]. The
resistance was set relative to body weight, age and gender, according to the manu-
factures instructions (boys 9-14 yr: 0,55 ·  body weight, boys 15-19 yr: 0,7 ·  body
weight, girls 9-14 yr: 0,53 ·  body weight, girls 15-19 yr: 0,67 ·  body weight). Before
starting the WanT the subjects were allowed a 1-min warm-up at 60 rpm against a
15 W resistance. The subjects were instructed to start pedalling as fast as possible
after the 1-min warm-up, while at the same time the full breaking force was applied
through a integrated computer program (Wingate 3.1, Lode, Groningen, The
Netherlands). Anaerobic performance indices were reported as peak power (PP;
highest power during the test) and mean power (MP; power averaged over 30-sec).
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Aerobic testing
Aerobic fitness was assessed by a standard progressive incremental exercise test.
After assessment of baseline cardiorespiratory values during a 3-min rest period, the
test started with pedalling at 60 rpm against a 15 W load. Thereafter, the workload
was increased by the constant increment of 15 W at 1-min intervals. Subjects exer-
cised to the limit of their tolerance. The maximal workload (Wmax) was defined as
the highest workload maintained during 30 seconds.
Continuous breath by breath respiratory gas analysis and volume meas-
urements were performed with a triple V valveless mouthpiece and stored in a com-
puterized exercise system (Oxycon Champion, Jaeger, Breda, The Netherlands).
Internal gas and volume calibrations were performed before each measurement.
Eight-breath averages of oxygen uptake (VO2), ventilation (VE) and CO2 exhalation
(VCO2) were measured during rest and exercise. 
The average of measurements made for the last 30 seconds of exercise was
taken as the individual’s VO2peak.
Efforts were considered to be at a maximum level if subjects showed clini-
cal signs of intense effort and were unable to maintain speed above 50 rpm [18], and
if at least one out of two criteria were met: 1) cardiac frequency above 180 beats/min;
2) maximal respiratory exchange ratio (i.e. VCO2/VO2) above 1.0 [19,20]. Predicted
values of VO2peak (VO2peak%) were obtained from an age and gender matched
Dutch reference population [21].
To allow ventilation at peak exercise (VEpeak) to be viewed in relation to ven-
tilatory capacity, it was examined as a percentage of predicted maximum voluntary
ventilation (VEpeak/MVV). MVV was estimated from the maximal expiratory flow-
volume curves as 40 times  FEV1 [11].
Data analysis
All data were tested for normality with the Shapiro-Wilks test. Pearson correlation
analyses and stepwise multiple regression analyses were performed for anaerobic
indices with nutritional status, muscle force, aerobic indices and pulmonary
function. 
As the CF group represents subjects with a wide range of pulmonary func-
tion, subjects were also categorized according to the level of pulmonary impair-
ment. Comparisons between subgroups were made with t tests for unrelated sam-
ples. Data were analyzed using the Statistical Package for the Social Science (SPSS,
version 9.0, Chicago. IL, USA). Comparisons were made for between-group differ-
ences in slopes and intercepts between regression lines with appropriate analyses
of covariance (ANCOVAs), according to the procedure outlined by Altman and
Gardner[22]. Differences were considered significant if p < 0.05 (two-tailed). Data
are presented as mean ± SD unless otherwise indicated.
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Table 1 Patient characteristics
Subjects (n=39)
Age (years) 13.2  ± 1.8
Length (cm) 155.9 ± 10.1
Weight (kg) 43.5 ± 9.8
BMI (kg/m2) 17.7 ± 2.3
FFM (kg) 31.0 ± 6.7
FEV1 (mL/min) 2139 ± 654
FEV1 (% predicted) 81.6 ± 22.1
FVC (mL/min) 2763 ± 707
VC (% predicted) 87.4 ± 16.8
RV/TLC (%) 34.0 ± 11.6
Data are means ± SD. BMI = body mass index; FFM = fat-free mass; 
FEV1 = forced expiratory volume in one second; FVC = forced vital capacity; 
VC = vital capacity; RV = residual volume; TLC = total lung capacity. 
Table 2  Correlation analysis for anaerobic performance with nutritional status,
muscle strength and aerobic performance
PP MP
FFM (kg) 0.893‡ 0.914‡
BMI (kg/m2) 0.589‡ 0.614‡
Body weight (kg) 0.880‡ 0.870‡
Elbow flexors (N) 0.680‡ 0.720‡
Shoulder abductors (N) 0.692‡ 0.724‡
Hip extensors (N) 0.543‡ 0.582‡
Knee extensors (N) 0.752‡ 0.778‡
VO2peak (mL/min) 0.761‡ 0.756‡
W (W) 0.724‡ 0.781‡
PP = peak power; MP = mean power; FFM = fat-free mass; BMI = body mass index; 
VO2peak = peak oxygen uptake; Wmax = maximum workload.  ‡p < 0.001.
Results
Subject characteristics are presented in table 1. Both exercise tests were well toler-
ated by all patients. Correlations of nutritional status, muscle force and aerobic exer-
cise with anaerobic performance are presented in table 2. The best correlations were
found between anaerobic performance and FFM, and to a lesser degree with other
indices of nutritional status. Significant correlations were found for anaerobic per-
formance with peripheral muscle force. Knee extensor force revealed the highest
correlations with PP and MP. With respect to aerobic performance, PP and MP
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correlated significantly with VO2peak and Wmax. Pulmonary function was not cor-
related with anaerobic indices. When FFM was controlled for in the multiple regres-
sion analysis significant correlations were found for anaerobic performance with
FEV1 (PP: r = -0.493; p < 0.01 and MP: r = -0.472; p < 0.01). Multiple regression
analysis revealed that FFM and FEV1% accounted for 82% of the variability in PP and
86% of variability in MP (compared to 77% and 82%, respectively, for FFM alone).
Body weight, BMI, muscle force and VO2peak were excluded from the regression
model.
CF-subgroups
The patients were also subdivided based on the degree of airway obstruction: a mild
group (N = 20, FEV1 ≥ 80 %) and a moderate group (N = 19, FEV1 < 80 %) (table
3). No differences were found in age between both groups (mild: 12.8 ± 2.1, moder-
ate: 13.5 ± 1.2). Subjects in the moderate group had significantly more airway
obstruction (FEV1: 99.2 ± 10.6% vs 62.9 ± 14.2%, p<0.001) and showed marked air
trapping (RV/TLC: 25.9 ± 8.0 vs 42.5 ± 8.1, p < 0.001). 
No significant differences were found for body weight (mild: 44.6 ± 11.6,
moderate: 42.4 ± 7.5) and FFM (mild: 31.1 ± 6.7, moderate: 28.9 ± 6.9), but BMI was
significantly lower in the moderate group (18.6 ± 2.8 vs 16.8 ± 1.3, p<0.05).
As shown in table 3, muscle force of the upper extremity muscle groups
was significantly lower in the moderate group while no differences were found for
the lower extremity muscle groups. Patients with mild or moderate lung dysfunction
had no significant different PP, MP, VO2peak and Wmax, but significantly different
VO2peak%. The moderate group used a significant larger part of their ventilatory
reserve and showed lower oxygen saturation at peak aerobic exercise. Pulmonary
limitation to aerobic exercise may involve an increase in EqVO2peak [4].  In our study
the moderate group had higher EqVO2peak compared to the mild group, but the
difference did not reach significance (p = 0.10).
Regression analyses of PP and MP (Y, given in W units) as a function of
FFM (X, given in kg) are shown in figures 1 and 2, respectively. Significant differ-
ences in fitted PP and MP between the two CF subgroups were found (PP: differ-
ence in vertical distance = 85 W [95% CI = 27 to 144 W], MP: difference in vertical
distance = 53 W [95% CI = 42 to 64 W]). When the slopes of the relationships for PP
and for MP were compared, no differences were found.
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Table 3 Physical performance compared between groups 
of patients with different pulmonary function
Mild Moderate
(n=20) (n=19)
Elbow flexors (N) 177 ± 33 154 ± 33 *
Shoulder abductors (N) 144 ± 32 112 ± 30 †
Hip extensors (N) 238 ± 66 205 ± 57
Knee extensors (N) 221 ± 62 211 ± 56
PP (W) 548 ± 187 576 ± 217
MP (W) 309 ± 97 321 ± 112
VO2peak (mL/min) 1666 ± 365 1605 ± 474
VO2peak (% of predicted) 87.0 ± 14.7 73.7 ± 12.5‡
Wmax (W) 137 ± 31 129 ± 38
VCO2peak (mL/min) 1905 ± 425 1734 ± 555
Eq VO2peak 41.9 ± 6.2 38.3 ± 7.0
Eq VCO2peak 36.5 ± 3.9 35.7 ± 6.2
VEpeak/MVV (%) 69.7 ± 10.2 88.3 ± 15.0 ‡
∆SaO2 (%) -1.6 ± 1.5 -4.4 ± 3.1 †
Values are presented as mean ± SD.  PP = peak power; MP = mean power; VO2peak = peak oxygen uptake;
Wmax = maximum workload; VCO2peak = carbon dioxide production; Eq VO2peak = ventilatory equivalent for
oxygen; Eq VCO2peak = ventilatory equivalent for carbon dioxide; VEpeak/MVV = peak ventilation as a percent-
age of predicted maximal voluntary ventilation; ∆SaO2 = percentage change in oxygen saturation;
* p < 0.05, †  p<0.01,  ‡p < 0.001.
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Figure 1 
Fat-free mass and peak power in CF patients with FEV1 < 80%  (open squares; dashed line) and with FEV1 ≥
80% (closed triangles; solid line). Regression equations (X = FFM [kg]; Y = peak power [W]): FEV1 < 80: Y = -
242.7 + 28.4 · X (r = 0.90, p < 0.001); FEV1 ≥ 80: Y = -243.7 + 25.8 · X (r = 0.90, p < 0.001)   
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Figure 2 
Fat-free mass and mean power in CF patients with FEV1 < 80% 
(open squares; dashed line) and with FEV1 ≥ 80% (closed  triangles; solid line). Regression equations (X =
FFM [kg]; Y = mean power [W]): FEV1 < 80: Y = -120.4 + 15.3 · X (r = 0.94, p < 0.001); FEV1 ≥ 80: Y = -110.5 +
13.5 · X (r = 0.92, p < 0.001).
Discussion
In recent years more research has focused on the physiological aspects of short-
term maximal exercise in patients with CF [10,23,24]. We studied the direct effects
of nutritional status, muscle force, aerobic capacity and pulmonary function on
anaerobic performance in children and adolescents with CF. Our results indicate
that FFM and pulmonary function are important determinants of anaerobic per-
formance in CF patients. Patients with moderate pulmonary dysfunction showed
a marked decrease in SaO2 during aerobic exercise testing. However, our results
also suggest that this patient group may have better anaerobic performance at
equivalent FFM compared to patients with mild or normal pulmonary function.
We showed that 77 – 82% of the variance in anaerobic exercise was
explained by FFM. This is consistent with the results of other studies in which
FFM has been found to be the most important determinant of anaerobic exer-
cise performance in patients with CF[3-5,25]. Although body weight and BMI were
significantly correlated with PP and MP, they were not independent predictors of
anaerobic performance. Since body weight of patients with CF consists of a high-
er proportion of FFM, due to fat depletion, correction for body weight is likely to
overestimate the power output of CF patients [19].These results are in agreement
with data of Boas et al. who showed that  differences in anaerobic performance
between children with CF and controls persisted after correction for FFM but not
when corrected for body weight [5]. These results suggest that FFM should be
used in favor of body weight or BMI to analyze anaerobic performance in rela-
tion to nutritional status.
Some remarks should be made on the use of bioelectrical impedance to
assess FFM in patients with CF. Impedance is affected by the intra- and extra-
cellular water distribution. Abnormal electrolyte transport in CF may potentially
affect fluid and electrolyte distribution [26] and thereby affecting the bioelectrical
impedance measurements. Despite the potential inaccuracies of using this
method, several studies have shown that bioelectrical impedance techniques
can be used in patients with CF by comparing this technique with other meas-
ures of body composition [12,27-31]. However, specific predictive equations for
patients with CF will need to be developed.
A general reduction in skeletal muscle function is common in patients
with CF [11,32,33]. Therefore, skeletal muscle dysfunction should also be consi-
dered when evaluating anaerobic exercise capacity in children with CF. To our
knowledge, this is the first study to document the relationship between periph-
eral muscle force and anaerobic exercise. Our results demonstrate that not all
muscle groups are equally important in evaluating anaerobic performance. Knee
extensors are the most important muscle group during sprint work on a cycle
ergometer. However, muscle force was not a determinant of anaerobic perform-
ance when we accounted for FFM. These findings are inconsistent with findings
regarding aerobic performance. De Meer et al. found a reduced aerobic per-
formance in children with CF, which was associated with a diminished peripher-
al muscle force, even in the absence of decreased FFM [11]. It is not clear whether
strength training can improve anaerobic performance in children with CF.
Selvadurai et al. reported an increase in leg strength after resistance training, but
no significant change was found in VO2peak [34].  Anaerobic performance how-
ever, was not assessed. 
Patients with CF suffer from progressive airway obstruction and hyper-
inflation, resulting in limited maximal oxygen uptake and hypoxemia. Until now,
the influence of pulmonary function on anaerobic performance has not been
clearly established. We demonstrated that PP and MP at equivalent FFM was
higher in a group of CF patients with moderate pulmonary dysfunction com-
pared to a group with mild pulmonary dysfunction. In contrast, Cabrera et al.
showed an association between a reduced anaerobic performance and worse
pulmonary function. [9] Other studies did not find a relationship between pul-
monary function and anaerobic indices [4,5,8].  Diversity in anaerobic exercise
tests and subjects might account for these differences. However, Boas et al. and
Cabrera et al. also used the WanT [5,9].  Cabrera et al. evaluated nutritional sta-
tus based on body weight and percentage ideal body weight. As shown in the
present study and the study of Boas et al. FFM instead of body weight should be
used in order to normalize indices of anaerobic performance. True effects may
be obscured  by the use of body weight. Ideally, the resistance used for the WanT
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should be based on FFM and not total body weight[15].  Boas et al. used FFM to
account for differences in PP and MP but severity of pulmonary disease was not
an independent determinant of anaerobic performance[5]. An explanation for
these opposite results is not readily apparent. Differences in the composition of
the CF-subgroups might be important. However, more research is needed in
order to clarify the different findings.
The higher anaerobic power output per FFM in our subjects with worse
pulmonary function was an interesting outcome. These findings suggest that
during progression of disease there is a shift from aerobic to anaerobic metabo-
lism possibly induced by recurrent hypoxemia. In most activities, energy for the
exercising muscle is supplied by both anaerobic and aerobic metabolism[35].
The relative contribution of both systems depends on the preferential use of the
systems (e.g. type of training). In children up to 40% of energy production in the
WanT test comes from aerobic processes [36].  In our group of patients,
VO2peak% was lower in the moderate group while their anaerobic performance
was higher compared to the mild group. This suggests a lower relative contri-
bution of aerobic energy production during the WanT in the moderate group. In
children with asthma it has been suggested that a reduced aerobic capacity
might be compensated for by an increase in anaerobic performance [37]. Varray
et al. suggested that due to earlier dependence on anaerobic metabolism during
aerobic exercise, anaerobic capacity in children with asthma might be main-
tained or enhanced [37].  Similar findings have been described in children with
CF with a reduced pulmonary function, in whom glycolytic metabolism was
markedly increased during anaerobic exercise, which was related to reduced pul-
monary function [3].
The better anaerobic performance in the patients with worse pulmonary
function may originate from several factors. Type II fibers with an anaerobic
metabolic profile have been shown to be positively correlated with anaerobic
exercise performance [38] and greater proportions of type II fibers could help
explain our results. In addition, a reduced metabolic efficiency has been report-
ed in CF patients [39,40]. Clinical factors, such as genotype may influence maxi-
mal anaerobic power in children with CF as well. The results of Selvadurai et al.
indicate that a relationship might exist between some measures of physical fit-
ness (peak aerobic capacity and PP) and CF genotype [41]. A limitation of our
study is that we did not assess daily physical activity. It has been shown that the
amount of daily physical activity is related to a diminished nutritional status [42]
and the amount of time spend in vigorous physical activities is associated with
lower aerobic fitness [43]. However, it is not clear whether anaerobic perform-
ance is influenced by daily physical activity. Therefor, no clear inferences can be
made on the cause of the differences seen in PP and MP between patients with
different pulmonary dysfunction. Further studies in patients with different clini-
cal conditions and in more homogenous age groups are needed to address the
observation of increased anaerobic performance in relation to pulmonary func-
tion.
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In conclusion, our study has shown that FFM and pulmonary function are
important determinants of anaerobic exercise performance in children with CF.
With progression of pulmonary disease, anaerobic performance may be
enhanced in children with CF. The underlying mechanisms need to be clarified.
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Abstract
The aim of this study was to validate the Dutch version of the Cystic Fibrosis
Questionnaire, which measures health-related quality of life, in school age chil-
dren (CFQ-C) and their parents (CFQ-P). The 35 item CFQ-C covers six domains
and two symptom scales. The CFQ-P consists of 43 items covering seven
domains, three symptom scales and one health perception scale.
Cross-sectional and test-retest designs were used to assess psychome-
tric characteristics of the CFQ. Sixty-eight children with CF (11.3 ± 1.9 years) and
their parents completed the questionnaires during a routine visit. 
Internal consistency was acceptable for most domains of the CFQ-C
(α=0.43-0.78) and the CFQ-P (α=0.47-0.93). Test-retest reliability was high for all
domains: CFQ-C (0.76 – 0.96) and CFQ-P (0.74 – 0.98). Construct validity of
both CFQ questionnaires was good, with moderate to strong correlations
between physically oriented CFQ-domains and pulmonary function (rs=0.35-
0.57), nutritional status (rs=0.46-0.51), inflammation (rs=0.40-0.53) and physi-
cal performance (rs=0.36-0.61). Both measures were able to differentiate
between two levels of disease severity. The convergence between the CFQ-C and
the CFQ-P was confirmed by strong correlations on observable domains
(rs=0.50-0.60). 
The CFQ questionnaires are reliable and valid measures of health-relat-
ed quality of life for use in children with CF and their parents.
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Introduction
Cystic fibrosis (CF) is a progressive disease, which eventually leads to reduction
in exercise capacity due to impaired pulmonary function and diminished nutri-
tional status. Physical limitations and disruptions of daily life activities have seri-
ous implications for the social and psychological well being of children [1]. It is
important to monitor the impact of disease progression and to assess the effect
of interventions on the health-related quality of life (HRQL) of children with CF.
Traditional clinical measures like pulmonary function and nutritional status are
important, but they do not capture the impact of the disease on physical, social
and psychological functioning [2-4]. As in other chronic pulmonary diseases,
somatic factors such as pulmonary function are poor predictors of the degree of
disability [5-7].
Studies on HRQL in children with CF have used generic questionnaires
[8]. Generic health measures allow for comparisons between a variety of dis-
eases, but are not sensitive to the specific problems associated with CF [2] and
they may not be sufficiently responsive to the effects of clinical interventions [4].
Recently a CF-specific health-related measure was developed and validated in
France, the Cystic Fibrosis Questionnaire (CFQ) [9], with a linguistically valid
translation of the measure completed in the United States [2].  In addition, the
CFQ has been validated in Germany [10] and is presently being validated in
Spain. The CFQ consists of three quality of life measures: a teen/adult version
(14 years of age or older), a child version (6-13 years of age) and a parent version
(used in conjunction with the child version). The CFQ takes into account the dif-
ferent developmental stages and makes it possible to monitor the health status and
quality of life of patients with CF from the age of 6 years throughout adulthood [2,11].
Cross-cultural validation of an existing measure has the advantage of
avoiding the initial stages of development of a new questionnaire, which is a
long process [12,13].  In addition, translation into different languages makes it
possible to use the CFQ questionnaires in comparative international multi-cen-
ter studies [10]. 
The aim of the present study was: 1) to develop a conceptually equivalent
Dutch version of the CFQ for school-age children 6 to 13 years, and for parents of
school-age children; 2) to evaluate the following characteristics: homogeneity, repro-
ducibility (10-14 days test-retest reliability), construct, discriminative and convergent
validity. The Dutch CFQ for teens and adults is presently being validated.
Methods
Patients and procedure
Sixty-eight patients were recruited from the CF-Center of the Wilhelmina
Children’s Hospital, University Medical Center Utrecht. Patients and their parents
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were approached during routine visits and asked for consent to complete the
CFQ. Patients and parents who had problems understanding the Dutch lan-
guage were excluded from the study. In a subset of parents and clinically stable
patients the questionnaire was administered twice within 10-14 days. The study
was approved by the appropriate Ethics Committee.
Translation
Backward and forward translations were made. The American version of the
child and parent CFQ developed by Quitener and colleagues was translated into
Dutch and translated back in English by a second independent translator [14,15].
The original American questionnaires for children and parents were compared
to their respective back translated versions. Apart from checking how literal the
back translated versions were in comparison to the original versions, discus-
sions were held to resolve semantic and conceptual discrepancies, in collabora-
tion with the developers of the original American questionnaires.
Cystic Fibrosis Questionnaire
The CFQ child version (CFQ-C) consists of 35 items divided into six domains:
physical functioning (six items), emotional state (nine), social limitations (six),
body image (three), eating disturbances (three) and treatment constraints
(three). Two symptom scales are included: respiratory (four) and digestive (one).
Seven-teen items require a frequency response, ranging from “all the time” to
“never” on a 4-point scale, and eighteen items require a true-false rating on a
4-point scale. For children between 6-11 years, the questionnaire was adminis-
tered by the researcher; children who were 12-13 years old completed the ques-
tionnaire themselves. Parents were not present when the CFQ was filled out.
Completing the questionnaire took approximately 10-15 minutes.
Parents’ report of their child’s disease-specific quality of life was mea-
sured using the CFQ parent version (CFQ-P). The CFQ-P consists of 43 items
which measure physical functioning (9 items), vitality (5), emotional state (5),
body image (3), performance at school (3), eating disturbances (2) and treat-
ment constraints (3). Three symptom scales, weight (1), respiratory (6) and
digestive (3), and a health perception scale (3) are included. Items require either
a frequency response on a 4-point scale (“all the time” to “never”), a difficulty
rating on a 4-point scale (“a lot of difficulty” to “no difficulty”), a true-false ra-
ting on a 4-point scale, or the selection of a statement that describes the child
(on a 4- or 5-point scale) [2]. Parents completed the questionnaire without the
child being present. Completing the questionnaire took approximately 10-15
minutes.
Scores are standardized by adding the ratings of all items within a
domain to facilitate comparison of scores across domains. The scores range
from 0 to 100 with higher scores corresponding to higher quality of life. Scores
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for each domain are calculated if at least two-thirds of the items are completed.
There is no total score.
Appendix A and B outline the distribution of the questions by domain
for CFQ-C and CFQ-P, respectively.
Homogeneity
Internal consistency of each domain was assessed using Cronbach alpha coeffi-
cients. Generally the internal consistency is considered acceptable with a
Cronbach alpha coefficient of 0.7 or above [16].  However, slightly lower coeffi-
cients (0.6 or higher) are acceptable for newly developed scales [17].
Furthermore, item to domain correlations were calculated. Psychometric guide-
lines suggest that item to domain correlations should be 0.40 or greater [17].
Reproducibility
Test-retest reliability measures the stability of the scores on the CFQ question-
naires over time. Eighteen patients with a stable clinical condition and their pa-
rents completed the CFQ 10-14 days apart. The questionnaire was mailed home
and patients and parents were asked to complete the questionnaire indepen-
dently. Children 6 to 11 years were interviewed by telephone and parents were
requested to leave the room.
Construct, discriminative and convergent validity
Construct validity was calculated by correlating CFQ scores with nutritional sta-
tus, pulmonary functioning, inflammation rate (the level of serum
immunoglobolin G (Ig-G)) and physical performance. Furthermore, we investi-
gated if other factors, related to the treatment and managing of CF (tube feed-
ing and aerosol therapy), were associated with HRQL.
To assess whether the measure could discriminate between patients
with varying degrees of disease severity, patients were categorized according to
the level of pulmonary impairment: mildly impaired group (FEV1 ≥ 80%pred)
and moderately impaired group (FEV1 < 80%pred) [18,19].  Since there was a lim-
ited range of illness severity in our study group, a severely impaired subgroup
could not be included. 
In addition, comparisons were made between younger (6-9 years) and
older (10-13 years) and between boys and girls. Convergent validity was obtained by
calculating correlation coefficients between CFQ scores for parent and child dyads.
Nutritional assessment 
Body weight was measured using a platform beam balance (Mettler, Greifen-
see, Switzerland) with an accuracy of 0,02 kg. Height was measured with a
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stadiometer (Holtain,Crymich, UK) with an accuracy of 0,1 cm. Body mass index
(BMI) was determined (weight.height-2). Standard deviation scores (z-scores,
expressed in sd units) were calculated for height, body weight and BMI from a
Dutch reference population [20].
Pulmonary function and inflammation
Forced vital capacity (FVC) and forced expiratory volume in one second (FEV1)
were obtained from maximal expiratory flow-volume curves (Masterscreen;
Jaeger, Wuerzburg, Germany). Residual volume (RV) and total lung capacity
(TLC) were measured in a constant-volume body plethysmograph (Masterlab;
Jaeger, Wuerzburg, Germany) and the RV/TLC ratios were calculated from the
actual values. Values are expressed as the percent of predicted values [21].
Serum immunoglobulin-G (IgG) was determined by enzyme-linked
immunosorbent assay (ELISA). IgG levels were used as an indicator of the sever-
ity of chronic lung infection and inflammation [22].
Physical performance
The standard exercise protocol for annual check-up measurements was used.
Until the age of 12 years, children perform a treadmill test according to the Bruce
protocol [23]. Children aged 12 years and older used an electronically braked
cycle ergometer (Lode Examiner; Lode, Groningen, The Netherlands). Workload
was increased by 15 W at 1-min intervals. 
The highest VO2 achieved during the last 30 seconds of exercise was
taken as VO2peak [24]. Predicted VO2peak (VO2peak %) values were obtained
from an age and gender matched Dutch reference population in which the same
modes of exercise were used [25].
Isometric muscle force measurements were performed for four muscle
groups (shoulder abductors, elbow flexors, hip-extensors and knee extensors) as
previously described [26]. Results for peripheral muscle force are presented as
total maximal muscle force (i.e. summed maximal force in four muscle groups,
since factor analyses showed a single-factor solution [Eigenvalue = 3.2; 81% of
total variance]).
Data analysis
The Statistical Package for the Social Sciences (SPSS for Windows version 10.1)
was used for data management and analyses. The internal consistency reliabili-
ty was evaluated using Cronbach’s α. Spearman (rs) correlation coefficients
were used to describe relationships between outcome measures. Strength of the
correlations was interpreted using criteria described by Guyatt and colleagues:
less than 0.2 as very weak, from 0.2 to 0.35 as weak, from 0.35 to 0.5 as moderate,
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and 0.5 or greater as strong [27]. Intraclass correlation coefficients were used to
estimate the reproducibility (test-retest reliability) [28]. Domain comparisons
between groups (disease severity, treatment issues, gender, age) were calculat-
ed using t tests for unrelated samples. Differences were considered significant if
p < 0.05 (two-tailed). Data are presented as mean ± SD unless otherwise indi-
cated.
Results
The majority of patients had mild pulmonary disaese and compared to age- and
gender-corrected values, had lower height, weight and BMI scores (table 1).
Most of the parents who completed the questionnaire were mothers (69%).
Table 2 shows mean (sd) values of the different domains. The lowest score on
the CFQ-Child version (CFQ-C) was found for Eating Disturbances while on the
CFQ-Parent version (CFQ-P) Health Perceptions, Body Image and Vitality
showed the lowest scores.
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Table 1 Patient characteristics
Subjects (n=68)
Age year 11.3 ± 1.9
height cm / SDSheight 144.9 ± 11.9 / -0.78 ± 0.91
weight kg / SDSweight 35.8 ± 9.5 / -0.58 ± 1.17
BMI kg•m2 / SDSBMI 16.7 ± 2.1 / -0.21 ± 1.12
FEV1 % pred 87.8 ± 20.8
FVC % pred 92.6 ± 16.9
RV/TLC % 32.8 ± 10.1
VO2peak % pred 85.6 ± 20.8
Total muscle force N 626.5 ± 174
Data are means ± SD. SDS: standard deviation score; BMI: body mass index; 
FEV1: forced expiratory volume in one second; FVC: forced vital capacity; 
RV: residual volume; TLC: total lung capacity; VO2peak: peak oxygen uptake.
Internal consistency 
Internal consistency coefficients (Cronbach alpha) for the domains of the CFQ-
C and CFQ-P are shown in table 2. Most domains in both questionnaires had
acceptable Cronbach alpha coefficients (0.60 or above). The exceptions to this
were Emotional and Social Functioning in the CFQ-C, and School Performance
in the CFQ-P. Overall, items in the CFQ-C and CFQ-P loaded conceptually on
their respective domains, with the majority of the loadings above 0.40. However,
in CFQ-C one item in the social functioning domain (“you felt comfortable sleep-
ing away from home”) was allocated to the emotional state domain since the
item domain correlation was far higher for the Emotional Functioning domain
(0.62 vs 0.26). The allocation of the item was considered justified, based on the
fact that Cronbach alpha of the Emotional Functioning domain increased from
0.52 to 0.70 after re-allocation. The Cronbach alpha for the Social Functioning
domain was only raised to 0.43. 
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Table 2 CFQ scores and Cronbach alpha for each domain on 
the CFQ-C and the CFQ-P
CFQ-C CFQ-P
CFQ score alpha CFQ score alpha 
coefficient coefficient
Physical Functioning 73.9 ± 23.2 0.78 82.4 ± 21.7 0.93
Emotional Functioning 81.1 ± 9.9 0.52 80.2 ± 17.7 0.80
Vitality - - 69.3 ± 12.5 0.65
Eating Disturbances 69.4 ± 23.1 0.60 74.4 ± 30.3 0.84
Body Image 84.4 ± 19.7 0.63 69.2 ± 25.6 0.64
Health Perception - - 67.2 ± 24.5 0.72
Social Functioning 81.1 ± 14.0 0.29 - -
Weight - - 76.1 ± 33.7 #
School Performance - - 76.2 ± 22.2 0.47
Treatment Burden 84.0 ± 15.8 0.68 73.8 ± 18.3 0.70
Respiratory Symptoms 77.1 ± 13.7 0.61 82.4 ± 16.5 0.80
Digestion 77.5 ± 21.1 # 71.5 ± 15.9 0.61
# is single item scale
Reproducibility
Eighteen patients (11.3 ± 2.4 years) and their parents (40.5 ±  4.3 years) partici-
pated in the test-retest reliability phase. The intraclass correlation coefficients
were high for all domains, ranging from 0.76 to 0.96 for the CFQ-C and from
0.74 to 0.98 for the CFQ-P. 
Construct, discriminative and convergent  validity
Moderate correlations were found between CFQ-C scores and pulmonary func-
tion, inflammation (IgG), nutritional status or physical performance (table 3).
With respect to CFQ-P scores, the relationships with pulmonary function,
inflammation, nutritional status or physical performance were moderate to
strong (table 4). The results indicate that children with worse pulmonary func-
tioning, higher levels of inflammation, lower nutritional status, aerobic capacity
or muscle force, report poorer quality of life on several domains. In addition,
patients who used tube feeding (yes: n=14; FEV1 71.6%, SDSBMI –1.0; no: n=54,
FEV1 90.9 %, SDSBMI –0.1) or aerosol therapy (yes: n=38, FEV1 82.3%; no: n=30,
FEV1 94.9%) reported  lower quality of life scores (table 3); their parents also
reported lower quality of life scores on several domains (table 4).
To assess whether the measure could differentiate between patients
with varying degrees of disease severity, patients were categorized according to
the level of pulmonary impairment. Two groups were formed: a mildly impaired
(N=43, FEV1 99.0 ± 12.2%) and moderately impaired group (N=25, FEV1 65.1 ±
15.4%). The moderate group had significantly lower scores on the Treatment
Burden domain (77.8 ± 11.1 vs 88.1 ± 15.8, p<0.01) and tended to be lower on the
Physical Function (66.1 ± 28.4 vs 77.9 ± 20.0, p=0.06) and Body Image domains
(80.0 ± 24.2 vs 89.9 ± 16.4, p=0.06). The CFQ-P scores for the patients with
moderate pulmonary impaiment were significantly lower for Physical
Functioning (71.6 ± 29.1 vs 86.6 ± 16.5, p<0.05), Vitality (64.0 ± 13.9 vs 71.6 ±
11.8, p<0.05), Body Image (55.0 ± 27.6 vs 74.9 ± 21.8, p<0.01) and Treatment
Burden (64.4 ± 19.6 vs 77.5 ± 16.5, p<0.01).
Comparisons between younger (6 to 9 year) and older children (10 to13
year), and between boys and girls revealed no differences in CFQ domain scores
on the child and parent versions.
Paired correlations were obtained on the CFQ-C and CFQ-P scores. Strongest
convergence was found for Physical Functioning (rs=0.60, p<0.001), Body
Image (rs=0.55, p<0.001) and Eating Disturbances (rs=0.50, p<0.001).
Moderate correlations were found for Respiratory Symptoms (rs=0.49, p<0.001)
and Emotional Functioning (rs =0.40, 0.01) and weak correlations for Digestion
(rs=0.32, p<0.05) and Treatment Burden (rs=0.29, p<0.05).
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Table 3 Correlation between CFQ Child scores and respiratory, 
nutritional or physical variables.*
PF ED BI TB RS
FEV1 %pred 0.42 - 0.41 0.34 0.35
FVC % pred 0.53 - 0.44 0.40 -
RVTLC % -0.34 -0.34 -0.47 - -0.43
Aerosol therapy -0.31 - - -0.33 -
IgG -0.45 - -0.53 - -
SDSBMI - - 0.46 - -
Tube feeding -0.32 - -0.40 - -
VO2peak %pred 0.42 - 0.54 - -
Muscle force N 0.37 - 0.45 - -
* Only the correlations with p < 0.01 and r > 0.3 are reported. PF: Physical Functioning; ED: Eating
Disturbances; BI: body image; TB: Treatment Burden; RC: Respiratory Symptoms; FEV1: forced expiratory
volume in one second; FVC: forced vital capacity; RV: residual volume; TLC: total lung capacity; IgG:
imunoglobulin G; SDS: standard deviation score; VO2peak: peak oxygen uptake.
Discussion
This study showed that the Dutch versions of the CFQ-C and CFQ-P are reliable
and valid disease-specific measures of HRQL for children with CF and their par-
ents. The internal consistency was acceptable for most domains of both CFQ-C
and CFQ-P, while the test-retest reliability was high. Several aspects of validity
were assessed. The construct validity with clinically relevant  parameters was
good. Furthermore, the CFQ was able to discriminate between levels of severity.
The association between patients’ and parents’ reports on observable domains
was high.
The internal consistency estimates of the CFQ-C and CFQ-P were ade-
quate, exceeding Ware’s criteria for newly developed scales [17]. Overall, the pa-
rent version showed higher internal reliability than the child version. Three
domains evidenced a low Cronbach alpha coefficient [17]. However, Emotional
Functioning (CFQ-C) improved to an acceptable level (0.7) after re-allocation of
one item from the Social Functioning domain. The Social Functioning domain in
the CFQ-C improved as well but remained low. An explanation for this low alpha
value is not readily apparent.  The item to domain correlations in the Social
Functioning domain were all equal to or above 0.40 and the items had no con-
current domains. Possibly, items in this domain (e.g. “you stayed at home more
than you wanted to”) are more associated with a social preference (e.g. playing
computer games) rather than a consequence of having CF [2]. In addition, it is
not yet clear whether HRQL questionnaires and response scales measure the
same concepts in different cultures [12]. Based on these analyses, minor revi-
sions should be made to capture specific patient problems in the Social
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Table 4 Correlation between CFQ Parent scores and respiratory, 
nutritional or physical variables.*
PF ED BI HP TB W RS
FEV1 %pred 0.57 - 0.47 0.37 0.45 0.32 0.41
FVC % pred 0.57 0.35 - - 0.49 0.39 0.40
RVTLC % -0.49 -0.39 -0.47 - -0.51 -0.34 -0.47
Aerosol therapy -0.31 - - - -0.34 - -
IgG -0.41 - -0.40 - - - -
SDSBMI - - 0.51 - 0.53 -
Tube feeding -0.44 - -0.33 -0.33 - -0.50 -
VO2peak %pred 0.55 0.36 0.61 - 0.45 0.44 0.38
Muscle force N - - - - 0.37 - -
* Only the correlations with p < 0.01 and r > 0.3 are reported. PF: Physical Functioning; ED: Eating
Disturbances; BI: Body Image; HP: Health Perception; TB: Treatment Burden; W: Weight; RS: Respiratory
Symptoms; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; RV: residual volume;
TLC: total lung capacity; IgG: imunoglobulin G; SDS: standard deviation score; VO2peak: peak oxygen
uptake.
Functioning domain. Recently Gee and colleagues developed and validated a
disease-specific quality of life measure for adolescents and adults with CF, which
showed better psychometric properties than the CFQ [29]. However, the advan-
tage of the CFQ is that it takes into account the different development stages
and makes it possible to monitor the health status and quality of life of CF
patients from the age of 6 years throughout adulthood [2,11].
School Performance in the CFQ-P showed low internal consistency. This
may be explained by the large number of missing items in this domain (25%),
causing a statistical power problem. In other domains, the number of missing
items was negligible (results not shown). This finding suggests that parents are
not sufficiently informed about the functioning of their children at school. More
research is needed to confirm this clinically relevant assumption.
The analysis of test-retest reliability showed high intraclass correlations,
indicating that the assessment of HRQL using the CFQs is stable over a 10 to 14
day period. This length of time was chosen to preclude participants from
remembering their prior responses, but short enough to prevent deterioration in
disease status [29].
Confirmation of the construct validity of the CFQ depends on significant
associations between CF-specific characteristics and relevant domains [30]. CF
is characterized by deterioration of nutritional status and irreversible loss of lung
function, both of which impair functional performance. In addition, inflamma-
tion has been associated with the systemic effect of CF, possibly leading to
changes in body composition (i.e. muscle wasting) [31]. The association between
CFQ scores on child and parent version and the clinical variables used for con-
struct validity, showed moderate to strong correlations. The discriminative value
of the CFQ questionnaires offered further evidence of validity. Although our
study group consisted of patients with a relatively low levels of pulmonary dys-
function, both questionnaires differentiated between two levels of disease sever-
ity, as measured by FEV1. Furthermore, specific treatment regimes like tube feed-
ing or the use of aerosol therapy affected quality of life on several domains. 
No differences were found between younger and older children. Since ill-
ness severity is related to older age (adolescents, adults) differences between
children in our age group were not expected. Gender differences were also not
statistically significant. Gender or age differences on certain domains (e.g. Body
Image) may become apparent when children reach puberty. 
The CFQ showed strong associations between parent and patient
reports on observable domains (Physical Functioning, Body Image and Eating
Disturbances), confirming the convergent validity of the measure. The weak to
moderate correlations found for other domains are probably caused by the fact
that these domains are less observable. Parents are less aware of social beha-
vior of their children, have a limited understanding of children’s internal state
[32], and children are reluctant to inform their parents about digestive difficul-
ties. In addition, parents may rate their children’s HRQL based on their own con-
cerns about the disease. It is important to note that not only is convergence
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between parents and children important, but parent’s HRQL scores may provide
complementary information about how the child and family is functioning.
Differences in scores might alert the health care team to potential problems in
either child or parent’s ability to cope with various aspects of the illness which
might be clinically detrimental [33].
Some issues of the present study need further comment. Although the
construct validity of the CFQ with clinical variables is good, assessment of its
relation with generic health status and psychological wellbeing should be done.
Data are needed on the responsiveness of the CFQ, which measures whether a
questionnaire is able to detect changes brought about by an intervention.
However, a prerequisite of sensitivity testing is establishment of the test-retest
reliability of the measure, which in this study, appears to be very good. Additional
testing of the discriminant validity of the CFQ-C and CFQ-P is needed  in order
to evaluate the CFQ’s performance in the full range of illness severity of young
patients with CF. 
In summary, the Cystic Fibrosis Questionnaire is a reliable and valid
measure of health-related quality of life for school-aged children with CF and
their parents. The CFQ questionnaires (child and parent forms) are valuable
instruments for measuring the multidimensional impact of the disease in clini-
cal practice. Cross-cultural comparisons are possible for all domains with the
exception of social functioning in CFQ child version. A study is presently under-
way to improve the consistency of this domain.
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Appendix A  CFQ child version
Domain Question Content of questions
Physical 1 Able to walk as fast as others
2 Able to climb stairs as fast as others
3 Able to run, jump, and climb as you wanted
4 Able to run as quickly and as long as others
5 Able to participate in all the sports that you enjoy
6 Difficulty carrying or lifting heavy things such as books
Emotional state 7 Had trouble listening in the class
8 Felt tired
9 Felt mad
10 Felt grouchy
11 Felt worried
12 Felt sad
13 Had trouble falling asleep
14 Had bad dreams or nightmares
15 Felt good about yourself
Social 21 Got together with friends
22 Stayed at home more than you wanted
23 Felt comfortable sleeping away from home…
24 Felt left out
25 Often invited friends to your house
26 Were teased by other children
Body image 27 Think you are too short
28 Think you are too thin
29 Think you are physically different from others your age
Eating 16 Trouble eating
18 Pushed to eat
20 Enjoyed eating
Treatment burden 17 Had to stop playing because of your treatments
19 Were able to do all of your treatments
30 Doing your treatments bothers you
Respiratory 31 Coughing during the day
32 Woke up during the night because of coughing
33 Cough up mucus
34 Trouble breathing
Digestion 35 Stomach hurt
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Appendix B  CFQ parent version
Domain Question Content of questions
Physical 1 Difficulty performing vigorous activities such as running
2 Difficulty walking as fast as others
3 Difficulty climbing stairs as fast as others
4 Difficulty carrying or lifting heavy objects
5 Difficulty climbing several flights of stairs
13 Difficulty walking a long time
14 Child absent or late for school
15 Participation in sports at school
16 Child has trouble recovering after physical effort
Vitality 8 Seemed tired
9 Seemed short-tempered
10 Seemed well
11 Seemed grouchy
12 Seemed energetic
Emotional state 6 Seemed happy
7 Seemed worried
23 Child tends to be withdrawn
25 Child has less fun than usual
26 Child has trouble getting along with others
Body image 19 Child feels small compared to other kids the same age
20 Child feels physically different from other children the same age
21 Child thinks he/she is too thin
School 27 Child has trouble concentrating
functioning 28 Child is able to keep up with his/her school work
29 Child is not doing as well as usual in school
Eating 17 Mealtimes are a struggle
disturbances 44 Child has eating problems
Treatment burden 18 Treatment gets in the way of activities
30 Difficult to do treatments each day
31 Time spent on treatments
Health 22 Child feels healthy
24 Child leads a normal life
32 How do you think child’s health is now?
Weight 33 Trouble gaining weight
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Appendix B [cont.]
Domain Question Content of questions
Respiratory 34 Congested
35 Coughing during the day
36 Cough up mucus
37 Description of child’s mucus
38 Wheezing
39 Trouble breathing
40 Woke up during the night because of coughing
Digestion 41 Gas
42 Diarrhea
43 Abdominal pain
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Abstract
Background: This study assesses the reliability and validity of the Dutch version
of a disease-specific measure of health-related quality of life (HRQOL) for ado-
lescents and adults with CF (CFQ-14+). The 47 item CFQ-14+ covers nine
domains, three symptom scales and one health perception scale. 
Methods: To assess psychometric characteristics of the CFQ-14+, cross-
sectional (homogeneity, discriminative and construct validity) and test-retest
designs were used. Eighty-four adolescents and adults with CF (mean age: 21.4
years, range 14.0 to 46.5 years) and moderate to severe airway obstruction
(mean FEV1: 59,9% predicted, range 15 to 121%) completed the questionnaire
during a routine visit. 
Results: Internal consistency was acceptable for most domains of the
CFQ-14+ (α=0.43-0.92) and test-retest reliability was high for all domain scores
(0.72 – 0.98). Several domains of the CFQ-14+ were able to differentiate between
individuals with varying disease severity and between nourished and malnou-
rished patients. Construct validity of the questionnaire was fair, with moderate to
strong correlation between physically orientated domains and pulmonary func-
tion (rs=0.36-0.62). 
Conclusion: The results demonstrate that the CFQ-14+ questionnaire is
a well validated measure of HRQOL assessment in adolescents and adults with CF.
.
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Introduction
Advances in therapy and treatment of cystic fibrosis (CF) have led to improved
patient survival into adulthood [1]. However, therapy and treatment of CF, coup-
led with the progressive nature of the disease, which can require hospitalization,
makes management of CF time-consuming and difficult [1,2]. Traditional clinical
measures are important but they do not capture the broader impact of the dis-
ease [3-5]. The measurement of health-related quality of life (HRQL) in CF pro-
vides additional information about the impact of the disease on physical, social
and psychological functioning [2,5,6]. Studies on HRQL in patients with CF have
typically used generic or specific respiratory questionnaires which were not
specifically developed for CF [7-12]. Generic health measures allow for compar-
isons between a variety of diseases, but are not sensitive for specific problems
associated with CF [6] and may not be sufficiently responsive to the effects of
clinical interventions. Recently a reliable and valid CF-specific health-related
measure was developed and validated in France, the Cystic Fibrosis
Questionnaire (CFQ) [13].  In addition, the CFQ has been validated in Germany
[14] and is presently being validated in the United States and Spain. The CFQ
consists of three quality of life measures: a adolescent/adult version (14 years of
age or older), a child version (6-13 years of age) and a parent version (used in
conjunction with the child measure). The advantage of the CFQ is that it takes
into account differences in developmental stages and makes it possible to mon-
itor the health status and quality of life in CF patients from the age of 6 years
throughout adulthood [6,15]. This allows health care professionals to analyze
long-term outcome and efficacy of early intervention. 
Cross-cultural validation of an existing measure has the advantage of
avoiding the initial stages of development of a new questionnaire, which is a
long process [16,17]. Furthermore, translation into different languages makes it
possible to use the CFQ questionnaires in comparative international multi-
center studies [14]. 
The aims of the present study were: 1) to develop a conceptually equi-
valent Dutch version of the CFQ for adolescents and adults with CF and 2) to
evaluate the following characteristics: homogeneity, reproducibility (10-14 days
test-retest reliability), discriminative and construct validity. 
The Dutch CFQ for children with CF and their parents is presently being
validated.
Methods
Patients and procedure
Eighty-four patients were recruited from the children and adult CF-Center of the
University Medical Center Utrecht. All patients were approached during routine
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visits between 2001 and 2002 and asked for consent to complete the CFQ.
Patients who had problems understanding the Dutch language were excluded
from the study. In a subset of clinically stable patients, as determined by a pul-
monologist, the questionnaire was administered twice within 10-14 days. The
study was approved by the institutional Medical Ethics Committee.
Translation
Backward and forward translations were completed. The French CFQ was trans-
lated into Dutch and a second independent translator made a backward transla-
tion into French. A third expert compared the original French list to the backward
translated French list. Discussions were held between the translators to resolve
semantic and conceptual discrepancies and to develop a consensus forward
translation. 
Cystic Fibrosis Questionnaire
The CFQ for adolescents and adults (CFQ-14+) consists of 47 items divided into
nine domains: physical functioning (8 items), energy and well-being (4), emo-
tional state (5), social limitations (4), role limitations (2), body image (3), eating
disturbances (2), treatment burden (2), and embarrassment (3). Three symptom
scales are included, respiratory (7), digestive (2), and weight (1), and overall
health perception (4). Items require either a frequency response on a 4-point
scale (“all the time” to “never”), a difficulty rating on a 4-point scale (“a lot of
difficulty” to “no difficulty”), a true-false rating on a 4-point scale, or the selec-
tion of a statement that describes the patient (on a 3- or 4-point scale) [6].
Completing the questionnaire took approximately 15-20 minutes.
Scores are standardized by adding the ratings of all items within a
domain to facilitate comparison of scores across domains. The scores range
from 0 to 100 with higher scores corresponding to higher quality of life. Scores
for each domain are calculated if at least two-thirds of the items are completed.
There is no total score.
Appendix A outlines the distribution of the questions by domain for
CFQ-14+.
Homogeneity
Internal consistency of each domain was assessed using Cronbach alpha coeffi-
cients (i.e. the strength of the associations between items and their respective
domains). Generally the internal reliability is acceptable with a Cronbach alpha
coefficient of 0.7 or above [18]. However, slightly lower coefficients (0.6 or
higher) are acceptable for newly developed scales [19]. Furthermore, item to
domain correlations were calculated. These correlations assess whether items
are more strongly associated with their hypothesized versus competing scale.
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Psychometric guidelines suggest that item to domain correlations should be
0.40 or greater [19].
Reproducibility
Test-retest reliability measures the stability of the scores on the CFQ question-
naires over time. Twenty-one patients with a stable clinical condition (i.e. no
need for oral or intravenous antibiotic treatment in three months prior to tes-
ting) completed the CFQ 10-14 days apart. 
Discriminative and construct validity
To assess whether the measure could discriminate between patients with vary-
ing levels of disease severity, patients were categorized according to their level
of pulmonary impairment:  mildly impaired group (FEV1 ≥ 71 %pred), mode-rate-
ly impaired group (FEV1 =  41 – 70 %pred) and severely impaired group (FEV1 ≤
40 %pred) [20]. In addition, patients were categorized according to their nutri-
tional status: nourished group (BMI ≥ 19) and malnourished group (BMI < 19).
Since disease severity is related to older age comparisons were made
between age groups: adolescents (14-17 years), young adults (18-25 years) and
adults (26 years of age and older). Comparisons were also made between males
and females. 
Construct validity was assessed by correlating CFQ scores with pul-
monary functioning.
Pulmonary function. 
Forced vital capacity (FVC) and forced expiratory volume in one second (FEV1)
were obtained from maximal expiratory flow-volume curves (Masterscreen;
Jaeger, Wuerzburg, Germany). Values are expressed as the percent of predicted
values [21,22].
Data analysis
The Statistical Package for the Social Sciences (SPSS for Windows version 10.1)
was used for data management and analyses. The internal consistency reliabi-
lity was evaluated using Cronbach’s α. Spearman (rs) correlation coefficients
were used to describe relationships between outcome measures. Correlations
were interpreted as described by Guyatt and colleagues: less than 0.2 as very
weak, from 0.2 to 0.35 as weak, from 0.35 to 0.5 as moderate, and 0.5 or greater
as strong.[23]  Intraclass correlation coefficients were used to estimate the repro-
ducibility (test-retest reliability) [24]. Domain comparisons between groups were
made using t-tests for unrelated samples and one way analysis of variance
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(ANOVA). Post hoc testing was done with Tukey’s honest significant difference,
which corrects for multiple comparisons. Differences were considered signifi-
cant if p < 0.05 (two-tailed). Data are presented as mean ± SD unless otherwise
indicated. 
Results
Eighty-four patients with CF (mean age: 21.4 years, range 14.0 to 46.5 years) who
had moderate to severe airway obstruction (mean FEV1: 58.5%, range 15 to 121%;
mean FVC: 74.1%, range 26 to 121%) completed the CFQ-14+. Table 1 shows
mean values of the different domains. The lowest scores on the CFQ-14+ were
found for Vitality and Respiratory Symptoms, while the highest scores were
found for Digestion and Embarrassment. 
Internal consistency 
The internal consistency reliability levels (Cronbach alpha) for the domains of
the CFQ-14+ are shown in table 1. Most domains had an acceptable Cronbach
alpha coefficient (0.60 or above). The exceptions to this were Body Image,
Treatment Burden and Embarrassment. Overall, items in the CFQ-14+ loaded
conceptually on their respective domains with all of the loadings above 0.40. 
Table 1 CFQ-14+ scores, Cronbach alpha and test-retest reliability 
for each domain
CFQ score Alpha Test-retest
(mean ± SD) coefficient reliability
Physical functioning 64.4 ± 25.7 0.92 0.98
Vitality 56.3 ± 17.6 0.81 0.90
Emotional state 77.7 ± 15.6 0.69 0.84
Social functioning 63.1 ± 24.8 0.64 0.97
Role limitations 60.6 ± 27.2 0.74 0.98
Body image 68.7 ± 21.2 0.45 0.89
Eating disturbances 78.0 ± 22.9 0.66 0.87
Treatment burden 61.7 ± 22.3 0.53 0.83
Embarrassment 80.1 ± 18.6 0.53 0.90
Respiratory constraints 53.0 ± 13.4 0.79 0.92
Digestion 84.1 ± 18.5 0.69 0.68
Weight 72.6 ± 32.8 # #
Health problems 70.6 ± 23.6 0.73 0.98
# is single item scale.
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Reproducibility
Twenty-one patients (22.8 ± 8.9 years; range 13.9 – 36.4 years) agreed to partici-
pate in the test-retest reliability phase. The intraclass correlation coefficient
werehigh for all domains, ranging from 0.72 to 0.98 (table 1). This means that
the domain scores of the CFQ-14+ are highly reproducible. 
Discriminative and construct validity
To assess whether the measure could differentiate between patients with varying
degrees of disease severity, patients were categorized according to the level of
pulmonary impairment. Three groups were formed: mildly impaired group
(N=28, FEV1 89.1% ± 14.0%), moderately impaired group (N=36, FEV1 56.0% ±
8.6%) and severely impaired group (N=20, FEV1 26.4% ± 7.1%). ANOVA tests
indicated significant main effects for Physical Functioning (F=27.34, p<0.001),
Body Image (F=13.43, p<0.001), Eat Disturbances (F=5.17, p<0.01), Respiratory
Symptoms (F=5.78, P<0.01), Health Perceptions (F=4.16, p<0.015) and Weight
(F=5.57, p<0.01). Table 2 shows significant post-hoc comparisons between CFQ
domains and disease severity. 
With respect to nutritional status, comparisons between the nourished
and malnourished group demonstrated that the nourished group had hi-gher
scores for Body Image (72.2 ± 16.8 vs 65.1 ± 18.3, p<0.05), Eating Disturbances
(83.3 ± 20.1 vs 72.4 ± 21.3, p<0.05) and Weight (77.5 ± 21.3 vs 67.1 ± 22.1, p<0.05).
Comparisons were made between adolescents (N=35; 15.4 ± 1.1 years),
young adults (N=31; 20.5 ± 1.4 years) and adults (N=18; 34.5 ± 6.3 years). ANOVA
tests indicated significant main effects for Physical Functioning (F=13.56,
p<0.001), Vitality (F=4.44, p<0.05), Body Image (F=6.29, p<0.01), Treatment
Burden (F=3.58, p<0.05), Respiratory Symptoms (F=9.87, P<0.01), Health
Perceptions (F=10.17, p<0.01). Post hoc analyses revealed the following differ-
ences between age groups: (1) adolescents reported higher quality of life than
young adults for the Body Image domain; (2) adolescents reported higher qua-
lity of life than adults for the domains of Physical Functioning, Vitality, Body
Image, Treatment Burden, Respiratory Symptoms, Digestion and Health
Perception; (3) young adults reported higher quality of life than adults for the
domains of Physical Functioning, Vitality, Respiratory Symptoms and Health
Perception. Comparisons between male (N=44) and female (N=40) patients
demonstrated that males had higher scores for the Emotional Functioning
domain (80.9 ± 12.2 vs 74.2 ± 18.1, p<0.05) and lower scores for the Body Image
domain (62.9 ± 24.3 vs 75.0 ± 15.0, p<0.01).
Table 3 shows weak to moderate correlations for pulmonary function
with Treatment Burden, Health Perceptions, Eating Disturbances, Weight,
Respiratory Symptoms, and strong correlations with Physical Functioning and
Body Image. The results indicated that patients with worse pulmonary function
reported poorer quality of life on these domains. 
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Table 3 Correlation between CFQ-14+ scores and pulmonary function.#
PF BI ED TC RC W HP
FEV1 %pred 0.62*** 0.52*** 0.33** 0.26* 0.36** 0.40*** 0.34**
FVC % pred 0.58*** 0.41*** 0.24* - 0.23* 0.40*** 0.27*
PF: physical functioning; BI: body image; ED: eating disturbances; TC: treatment constraints; RC: respi-
ratory constraints; W: weight; HP: health problems; FEV1: forced expiratory volume in one second; FVC:
forced vital capacity.
#Only significant correlations are reported.  *p<0.05, **p<0.01, ***p<0.001.
Discussion
This study assesses the reliability and validity of the Dutch version of a disease-
specific measure of HRQL for adolescents and adults with CF (CFQ-14+). The
conceptual model of the CFQ was confirmed and the internal consistency was
acceptable for most domains. Strong test-retest reliability was obtained and dis-
criminative validity with pulmonary function, nutritional status and age was
demonstrated. 
The homogeneity of the CFQ was sufficient since all of the items
showed higher correlations with the intended scale than with a competing scale.
The internal consistency reliability estimates of the CFQ-14+ were adequate,
exceeding Ware’s criteria for newly developed scales[19]. However, three
domains showed a low Cronbach alpha coefficient. Internal consistency coeffi-
cients of the Treatment Constraints domain have found to be even lower in pre-
vious studies [25]. One possible reason for this is that early detection leads the
initiation of treatment regimens at a very young age. Patients may slowly
accommodate to deterioration in their health status and a concomitant increase
in the treatment regimen.  Therefore, they may not perceive this as limiting their
daily functioning. Internal consistency on the Body Image domain was also poor.
The low alpha coefficient was, in part, caused by a gender effect. The Cronbach
alpha for males and females was 0.56 and 0.10, respectively. However, deleting
gender-based items or scales could lead to losing important information related
to males and females with CF. For example, there is a significant gender differ-
ence in morbidity and mortality among males and females with CF which may
be better understood in relation to their HRQL scores [26]. Calculations of inter-
nal consistency are strongly determined by the number of items on each scale
[27]. Possibly, Body Image, Treatment Burden and Embarrassment have not
enough items to highlight specific patient problems. Based on these analyses,
revisions should be made. Recently, we added new items to these domains to
solve this problem. These items will be tested in subsequent studies with the CFQ.
Currently there is only one other validated CF-specific HRQL measure
for adolescents and adults (CFQoL) [20]. The authors reported high Cronbach
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alpha coefficients on all domains. However, this measure does not have a ver-
sion for children with CF and their parents. The CFQ questionnaires make it pos-
sible to follow individual patients throughout their life span and to capture the
impact of the disease on the patient’s ability to cope with various aspects of the
illness.  Furthermore, there was no effort to counterbalance positively and nega-
tively worded items on the CFQoL, which can skew the wording of the items in
a negative direction (“CF makes it difficult for me to….”).
The analysis of test-retest reliability showed high intraclass correlations,
indicating that the assessment of HRQL is stable over a 10 to 14 day period. This
period is long enough not to introduce memory as a confounding factor while
being short enough to prevent deterioration in disease status [20].
Generic quality of life measures do not capture the symptoms and areas
of functioning that are relevant for majority of patients with a particular disease
[5,27]. Confirmation of the discriminative and construct validity of the CFQ
depends on the significant associations found between specific measures of dis-
ease impairment  and relevant domains. CF is characterized by deterioration of
nutritional status and irreversible loss of lung function, which impairs functio-
nal performance. The CFQ-14+ differentiated between three levels of disease
severity (as measured by FEV1) and between nourished and malnourished
patients 
Important differences were also found between younger and older
patients. In addition, gender differences were found for Body Image and
Emotional Functioning. These findings converge with the results of other stu-
dies, showing that gender differences exist in morbidity and mortality with CF
[26,28]. Thinness and low body weight are perceived by women as less of a prob-
lem than males [6], although this condition is unfavarouble for their health [29-
31]. Furthermore, it is well-documented that woman report more emotional pro-
blems due to poor health than men [20]. 
The construct validity of the CFQ-14+ offered further evidence of validity.
The CFQ-14+ domains Physical Functioning, Body Image, Respiratory
Symptoms and Weight showed moderate to strong correlations with pulmonary
function parameters. Weak correlations were found for Treatment Burden and
Health Perceptions. 
Some issues in the present study need further comment. The sample
size for this study was relatively small. Possibly stronger evidence of reliability
might have been found in the Treatment Constraints, Body Image and
Embarrassment domains with a larger sample size.  Although the construct
validity of the CFQ-14+ with pulmonary function is good, assessment of its rela-
tionship to generic health status and psychological well-being should be con-
ducted. Data are also needed on the responsiveness of the CFQ-14+, which
measures whether a questionnaire is able to detect changes brought about by an
intervention. However, a prerequisite of sensitivity testing is the establishment
of the reliability and stability of  the measure, which in this study, appears to be
5
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very good. Evaluation of the child and parent versions of the CFQ is presently
underway. 
In summary, although revisions are needed to improve the psychomet-
ric performance of the Cystic Fibrosis Questionnaire, this measure holds prom-
ise for assessing health-related quality of life in adolescents and adults with CF. 
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Appendix A  List of items of the Dutch CFQ-14+
Domain Question Content of questions
Physical 1 Difficulty performing vigorous activities such as running or sports
2 Difficulty to walk as fast as others
3 Difficulty carrying or lifting heavy things such as books
4 Difficulty climbing one flight of stairs
5 Difficulty to climb stairs as fast as others
13 Difficulty walking
19 Trouble recovering after physical effort
20 Limit vigorous activities such as running or sports
Vitality 6 Felt happy
9 Felt tired
10 Felt energetic
11 Felt exhausted
Emotional state 7 Felt worried
8 Felt useless
12 Felt sad
28 Difficult to make plans for the future
33 Feel lonely
Social 22 Stayed at home more than you wanted
26 Feel comfortable sleeping away from home…
30 To get together with friends a lot
32 Feel comfortable going out at night
Role 37 Absent from school or work because of illness or treatments
39 Trouble keeping up with school, work or daily activities
Body image 23 Think you are too thin
24 Think you are physically different from others your age
25 Feel bad about physical appearance
Eating 14 Feel about eating
21 Force myself to eat
Treatment 15 Treatment makes daily life more difficult
constraints 16 Time spend on treatment each day compared to one year ago
Embarrassment 27 People ask uncomfortable questions
29 People are afraid that my illness may be contagious
31 Think coughing bothers others
Health 17 Health at this moment
18 Health compared to three months ago
34 Feel healthy
35 Lead a normal life
Weight 40 Trouble gaining weight
5
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Appendix A [cont.]
Domain Question Content of questions
Respiratory 41 Felt congested
42 Coughing during the day
43 Cough up mucus
44 Color mucus
45 Wheezing
46 Trouble breathing
47 Woke up during the night because of coughing
Digestion 48 Diarrhea
49 Abdominal pain
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Abstract
Children’s physical activity pattern is characterized by short-term anaerobic
activities. Anaerobic exercise performance in children with cystic fibrosis (CF)
has received little attention compared to aerobic performance. This study inves-
tigated the effects of anaerobic training in children with CF.
Twenty patients were randomly assigned to the training group (TG)
(n=11; age 13.6 ± 1.3 yrs, FEV1%predicted 75.2 ± 20.7%) or control group (CG)
(n=9; age 14.2 ± 2.1 yrs, FEV1%predicted 82.1 ± 19.1%). The TG trained two days
per week for 12 weeks with each session lasting 30-45 minutes. The training pro-
gram consists of anaerobic activities, lasting 20 to 30 seconds. Body composi-
tion, pulmonary function, peripheral muscle force, habitual physical activity, aer-
obic and anaerobic exercise performance, and quality of life were re-evaluated at
the end of the training program and again after a 12-week follow-up period.
TG significantly improved their anaerobic performance, aerobic per-
formance and quality of life. No significant changes were seen other parameters
and no improvements were found in CG. After the follow-up period only anaer-
obic performance and quality of life in TG were significantly higher compared to
pretraining values.
Anaerobic training has positive effects on aerobic and anaerobic per-
formance and health-related quality of life in children with CF. Therefor, anaero-
bic training could be an important component of training programs for CF
patients. 
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Introduction
Regular aerobic exercise has positive effects on the aerobic capacity of patients
with cystic fibrosis (CF) [1-3]. In addition, higher aerobic fitness has been asso-
ciated with prolonged survival and quality of life [4,5]. Compared to aerobic stud-
ies little attention has been given to anaerobic fitness. Especially controlled stud-
ies on the effect of anaerobic training in children and adolescents with CF are
lacking. This is somewhat surprising since children’s natural activity patterns are
characterized by very short vigorous bouts of physical activity, interspersed with
varying levels of low to moderate intensity [6]. Therefore, physical activity pat-
terns in children may be more suited for a high intensity, anaerobic training program.
Several studies showed reduced anaerobic performance in children with
CF [7-12]. In addition, children with CF do not participate as much in activities
with high intensity compared to healthy controls [13].
It has been shown that healthy children’s anaerobic performance can be
enhanced through participation in structured exercise programs [14,15]. Besides
an increase in anaerobic performance, Rotstein and colleagues reported an
increase in aerobic performance as well after an anaerobic training program [14].
It is not clear whether anaerobic training can improve anaerobic and aerobic fit-
ness in children with CF.
With respect to the importance for daily functioning, the aim of this
study was therefore to investigate the effects of an anaerobic training program
on anaerobic and aerobic performance, lung function, body composition,
peripheral muscle strength and health-related quality of life (HRQL) of children
with CF.
Methods
Subjects
Children with CF were recruited from the CF-Center, University Medical Center at
Utrecht. Inclusion criteria were: children aged 9 -18 years with a stable clinical
condition (no need for oral or intravenous antibiotic treatment in three months
prior to testing), absence of musculo-skeletal disorders and a forced expiratory
volume in 1 sec (FEV1) > 30% predicted. Twenty-three patients agreed to partic-
ipate. Our institutional Ethics Committee approved the study protocol. Informed
consent was obtained from each participant and from his or her parent.
Study protocol
After the baseline measurements the tests were repeated within seven days after
the training program was finished, and again 12 weeks later. The study was
designed as a randomized controlled trial. After the pretraining tests the children
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were randomly assigned by concealed opaque envelopes to either the training
group (TG) or the control group (CG). The control subjects were asked to con-
tinue their normal daily activities as well as their physiotherapy regime. The pri-
mary researcher was blinded for the experimental condition.
Nutritional assessment
Anthropometric measurements were made prior to exercise testing. Fat free
mass (FFM) was determined in fasting condition using bioelectrical impedance
techniques. Body weight was measured using a platform beam balance (Mettler,
Greifensee, Switzerland) with an accuracy of 0,02 kg. Height was measured with
a stadiometer (Holtain,Crymich, UK) with an accuracy of 0,1 cm. Body mass
index (BMI) was determined (weight.height-2). 
Pulmonary function tests
Pulmonary function tests were performed after inhalation  of 800 µg of  salbu-
tamol via metered dose inhaler with a spacer, in order to rule out important
bronchial hyperreactivity. Forced vital capacity (FVC), forced expiratory volume in
one second (FEV1) and forced expiratory flow between 25 and 75% of expiratory
vital capacity (FEF25-75) were obtained from maximal expiratory flow-volume
curves (Masterscreen; Jaeger, Wuerzburg, Germany). Residual volume (RV) and
total lung capacity (TLC) were measured in a volume-constant body plethysmo-
graph (Masterlab; Jaeger, Wuerzburg, Germany) and the RV/TLC ratios were cal-
culated from the actual values. Values are expressed as the percent of predicted
values [16].
Peripheral muscle strength
Isometric muscle force measurements were performed for four muscle groups
(shoulder abductors, elbow flexors, hip-extensors and knee extensors) according
to the description of Backman [17]. Results for peripheral muscle force are pre-
sented as total maximal muscle force (i.e. summed maximal force in four mus-
cle groups, since factor analyses showed a single-factor solution [Eigenvalue =
2.7; 68% of total variance]).
Exercise testing
Subsequent anaerobic and aerobic exercise tests were performed on an elec-
tronically braked cycle ergometer (Lode Examiner, Groningen, The Netherlands).
All subjects were familiar with the different tests and equipment used. During
the tests heart rate was monitored continuously by 3-leads electrocardiogram
(Hewlett-Packard, Amstelveen, The Netherlands) and oxygen saturation (SaO2)
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by pulse oximetry (Nellcor 200 E, Breda, The Netherlands). Verbal encourage-
ment was given throughout the tests to stimulate maximal performance.
Each subject performed a Wingate anaerobic Test (WanT) to assess
anaerobic performance.[18] The WanT is a valid and reliable test to evaluate
short-term anaerobic power in healthy children, children with CF and other
chronic illnesses [7,11,18,19]. The subjects were instructed to start pedaling as
fast as possible after a 1-minute warming-up against 15 W resistance, while at the
same time the full breaking force was applied through an integrated computer
program. Anaerobic performance indices were reported as mean power (MP;
power averaged over 30 seconds) and peak power (PP; highest power during the test).
After the WanT the subjects rested for at least 45 minutes before aero-
bic fitness was assessed by a standard progressive incremental exercise test.
Workload was increased by 15 W at 1-min intervals. The maximal workload
(Wmax) was defined as the highest workload maintained during 30 seconds.
Continuous respiratory gas analysis and volume measurements were performed
breath by breath with a triple V valveless mouthpiece and stored in a computer-
ized exercise system (Oxycon Champion, Jaeger, Breda, The Netherlands).
Internal gas and volume calibrations were made before each test. Measurements
taken included oxygen uptake (VO2), carbon dioxide production (VCO2), venti-
lation (VE) and respiratory exchange ratio (RER= VCO2/VO2). The highest VO2
achieved during the last 30 seconds of exercise was taken as VO2peak [8]. 
Efforts were considered to be at a maximum level if subjects showed
clinical signs of intense effort and were unable to maintain speed above 50 rpm
[20], and if at least one out of two criteria were met: 1) cardiac frequency above
180 beats/min; 2) maximal RER above 1.0 [21,22]. Predicted VO2peak
(VO2peak%) values were obtained from an age and gender matched Dutch refer-
ence population [23]. 
Lactate
Blood samples were drawn three minutes after peak aerobic exercise, from an
antecubital vein and collected in Vacutainer tubes and subsequently analyzed
(Vitros 250 analyzer, Johnson & Johnson, Clinical Diagnostics, Rochester, USA).
Daily physical activity
Physical activity was assessed with the Habitual Activity Estimation Scale
(HAES) [24]. This scale reviews the subject’s activity level for two weekdays dur-
ing the last two weeks. The total percentage of time being active is presented.
The HAES has been used in children with CF [25,26] and in other studies of chil-
dren with chronic disease [27].
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Quality of life
Quality of life was measured with a disease-specific health-related quality of life
questionnaire, the Cystic Fibrosis Questionnaire (CFQ). The CFQ consists of a
47 item teen/adult version (CFQ-14+) and a 35 item child version (CFQ-C)
[28,29]. The CFQ takes into account the different developmental stages and
makes it possible to monitor the health status and quality of life of patients with
CF from the age of 6 years throughout adulthood [28,29].
Anaerobic training program
The subjects in the training group (TG) trained on a individual basis and the
standardized training sessions were led by the children’s own physiotherapist.
Specific written instructions in the form of a booklet were given to the physio-
therapists. The TG trained two days per week for 12 weeks. Each session lasted
30-45 minutes. Guidelines based on a review of anaerobic training studies in
children were used [30]. The training program consists of eight basic training
sessions (running lanes and movement games, lasting 20 to 30 seconds) which
were repeated every four weeks. Individual scores and changes in training over-
load were carefully recorded in a logbook. The children were constantly encour-
aged to exercise at maximal speed. 
Data analysis
Data are presented as mean ± SD. All data were tested for normality with the
Shapiro-Wilks test. The analysis of variance for repeated measures was used for
within- and between group comparisons. Between-group comparisons were
made with an unpaired t-test. Changes within the two groups were analysed with
a two-tailed paired t-test. Pearson correlation analyses and linear regression
analyses were performed for HRQL with aerobic and anaerobic indices. Data
were analysed using the Statistical Package for the Social Science (SPSS, version
9.0, Chicago. IL, USA).
To achieve a difference in peak power per kg body weight of 10% with a
SD of 0.8 W/kg and a statistical power of 80%, it was calculated that eight
patients had to be included in each study group.
Results
Twenty-three patients were initially enrolled. Two patients (FEV1: 37,5 ± 7,8%) in
the control group failed to complete the study because of pulmonary exacerba-
tion and one patient (FEV1: 105%) in the training group withdrew from the study
for practical reasons. The baseline characteristics of the remaining twenty
6
79
patients are shown in table 1 and the baseline results for anaerobic and aerobic
performance are shown in table 2. Both exercise tests were well tolerated by all
patients and all patients fulfilled the criteria for a maximal aerobic exercise test.
Comparisons between groups revealed no significant differences at baseline. 
The adherence of the training group to the exercise training was excel-
lent. The attendance rate at the exercise sessions was 98.1 ± 4.3%. Reasons for
absence were holidays and sickness.
Effects of exercise training
Body composition, pulmonary function, muscle force and habitual physical activity
At the end of the 12-week training period, a significant within group increase was
found for height (TG 1.5  ± 0.9 cm, p<0.001; CG 1.1 ± 1.0 cm, p<0.05) and weight
(TG 0.4 ± 0.6 kg, p<0.05; CG 0.8 ± 1.0, p<0.05). With-in and between-group
comparisons revealed no significant differences for body composition, pul-
monary function, peripheral muscle force and habitual physical activity at the
end of the training period.
Anaerobic and aerobic performance
The changes observed after the 12-week training period for anaerobic and aero-
bic performance are shown in table 3. TG showed significant improvements in
absolute PP (11.7%) and MP (12.4%), in PP and MP per kg body weight (BW)
(10.9% and 10.1%, respectively) and PP and MP per kg FFM (11.8% and 11.9%,
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Table 1  Baseline characteristics of the training group and the control group
Training group (n=11) Control group (n=9)
Age years 13.6 ± 1.3 14.2 ± 2.1
Height cm 155.5 ± 8.2 159.8 ± 8.5
Weight kg 41.9 ± 5.9 47.7 ± 8.7
BMI kg/m2 17.2 ± 1.0 18.5 ± 2.3
FFM kg 27.9 ± 3.4 31.4 ± 4.6
FEV1 % pred 75.2 ± 20.7 82.1 ± 19.1
VC % pred 85.0 ± 14.0 93.2 ± 15.8
FEF25-75 % pred 54.1 ± 45.3 51.0 ± 30.6
RV/TLC % 37.2 ± 11.2 32.6 ± 8.7
Isometric muscle force Nm 648 ± 118 668 ± 78
Activity level % 25.6 ± 13.7 25.9 ± 19.1
Data are means ± SD. BMI: body mass index; FFM: fat-free mass, FEV1: forced expiratory 
volume in one second; VC: vital capacity; FEF25-75: forced expiratory flow at 25-75% of VC, 
RV: residual volume; TLC: total lung capacity. p = NS for all between-group comparisons.
respectively). With respect to aerobic measurements, TG showed significant
improvements in VO2peak (mL/min: 5.2% and %predicted: 5.7%), Wmax (7.9%)
and serum lactate (26.1%) while the increase in VO2peak per kg FFM (5.2%) was
not significant. In CG a significant decrease was found for VO2peak per kg BW (-
1.5%) and per kg FFM (-5.6%), while other parameters were unchanged.
Quality of life
At the end of the 12-week training period, a significant higher score was found in
the domain of Physical Functioning in TG (70.3 ± 13.8 versus 88.4 ± 9.0,
p<0.001) but no change was found in CG (83.2 ± 18.5 versus 87.1 ± 17.9, p=0.20)
or in other quality of life domains.
Regression analysis in TG indicated that the change in PP accounted for
41% of the variance in the Physical Functioning domain (p<0.05). Changes in
MP or VO2peak were not independent correlates of changes in quality of life
scores.
Effects of follow-up period
Comparing pretraining and end of the follow-up period, a significant increase
was found for height (TG 2.8 ± 1.0 cm, p<0.001; CG 2.1 ± 1.2 cm, p<0.01), weight
(TG 1.7 ± 1.5 kg, p<0.01; CG 1.7 ± 1.3 kg, p<0.01) and FFM (TG 2.0 ± 2.3 kg,
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Table 2  Baseline results for anaerobic and aerobic performance
Training group Control group 
(n=11) (n=9)
Anaerobic performance
Peak power W 547 ± 178 647 ± 179
W/kg BW 12.8 ± 2.5 13.4 ± 1.6
W/kg FFM 18.7 ± 3.7 20.3 ± 3.2
Mean Power W 296 ± 92 365 ± 104
W/kg BW 6.9 ± 1.3 7.7 ± 0.9
W/kg FFM 10.1 ± 1.8 11.4 ±1.8
Aerobic performance
VO2peak mL/min 1677 ± 242 1904 ± 330
mL/kg·min 40.2 ± 4.2 40.7 ± 8.3
mL/kg·FFM 60.1 ± 5.4 60.8 ± 8.4
%predicted 83.1 ± 9.1 84.2 ± 10.4
Wmax W 140 ± 20 156 ± 26
Lactate mmol/L 6.9 ± 1.9 9.6 ± 4.0
VO2peak = peak oxygen uptake; BW = body weight; FFM = fat-free mass; 
Wmax = maximal workload p = NS for all between-group comparisons.
p<0.05; CG 1.7 ± 1.2 kg, p<0.05) but no changes were found for habitual physi-
cal activity. However, between-group comparisons of changes observed at the
pretraining assessment as compared with end of the follow-up period were not
significant. BMI, pulmonary function, peripheral muscle force and habitual phys-
ical activity did not change significantly in both groups. 
TG showed significant higher follow-up levels of absolute PP (54.6 ±
47.7 W, p<0.001) and MP (24.9 ± 73.5 W, p<0.01) when compared with pretrain-
ing levels The increase in CG was not significant compared to baseline values
(PP 21.7 ± 15.6, p=0.34; MP 12.7 ± 34.4, p=0.31). All other anaerobic indices
decreased to baseline values. 
With respect to aerobic performance, no significant differences were
found in the TG between baseline and end of follow-up period. CG showed sig-
nificant lower VO2peak (kg BW -1.5 ± 1.7 mL/kg·min, p<0.05; kg FFM –3.0 ± 1.9
mL/kg·min) and serum lactate (-1.2 ± 1.2 mmol/L, p<0.05) when pretraining and
end of follow-up period were compared.
At the end of the follow up period, the domain of Physical Functioning
in TG (8.3 ± 8.4, p<0.01) was still significantly higher compared to pretraining
values.
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Table 3  Effect of training program on anaerobic and aerobic performance
Training group Control group 
(n=11) (n=9)
Anaerobic performance
Peak power W 66.9 ± 23.8*** -3.4 ± 53.7
W/kg BW 1.4 ± 0.6*** -0.3 ± 1.1
W/kg FFM 2.2 ± 1.2*** -0.6 ± 2.0
Mean Power W 36.6 ± 11.8*** -6.7 ± 29.9
W/kg BW 0.7 ± 0.3*** -0.3 ± 0.8
W/kg FFM 1.2 ± 0.6*** -0.4 ± 1.1
Aerobic performance
VO2peak mL/min 88 ± 106* -48 ± 63
mL/kg·min 1.5 ± 2.6 -0.6 ± 1.9*
mL/kg·FFM 1.3 ± 4.6 -3.2 ± 2.5**
%predicted 4.7 ± 5.6* -2.1 ± 2.8
Wmax W 11 ± 14* -2 ± 5
Lactate mmol/L 1.8 ± 1.4** -1.6 ± 2.9
Values are mean ± SD. Significant differences from baseline values are indicated. 
BW = body weight; FFM = fat-free mass; VO2peak = peak oxygen uptake; 
Wmax = maximal workload. *p<0.05, ** p<0.01, *** p<0.001; p = NS for all other 
within- and between-group comparisons. 
Discussion
The aim of this study was to investigate the effects of an anaerobic training pro-
gram in children with CF. In this single blind, randomized controlled study, after
a 12-week training period, improvements were observed in anaerobic and aero-
bic outcome parameters and in HRQL. In addition, at the end of a 12-week fol-
low-up period most outcome parameters decreased to pretraining values with
the exception of anaerobic performance and HRQL.
To our knowledge, this is the first study to document that children with
CF are able to improve their anaerobic exercise capability through a high-inten-
sity training program. These results are in agreement with anaerobic training
studies in healthy children [14,31]. TG increased their PP with 12.2%, which com-
pares favorably with the results of McManus and colleagues after a three-times
a week, 8-week sprint-running training program in healthy girls (PP: 9.7%) [32].
Rotstein and colleagues reported an increase in PP and MP per kg BW (14% and
10%, respectively) after a 9-week, 3 times per week training program [14]. These
results are consistent with the increase found in our study (PP/kg BW 11% and
MP/kg BW 10%). Grodjinovsky and colleagues reported much lower improve-
ments in MP per kg BW (3-4%) and PP per kg BW (4%) after a 6-week 3-times
per week anaerobic training program in 11-13 year old healthy children [15].
Although guidelines for anaerobic training in children are not yet clearly estab-
lished [30], the outcome of these findings suggest that a minimal time-period of
approximately 8 weeks would be likely to induce a substantial improvement in
pediatric anaerobic fitness.
Changes in aerobic exercise capacity are usually associated with speci-
fic training programs involving several hours per week at submaximal intensity
[33]. Although the intensity of our training program may be considered as very
stressful and the duration of the exercises very brief, anaerobic training resulted
in an increase in VO2peak (5%). This result is in accordance with studies in
healthy children that show an increase of aerobic capacity of 4-7%  after anaero-
bic training [14,34]. These results may be explained by the fact that resynthesis of
adenosine triphosphate (ATP) during high-intensity exercise depends on both
aerobic and anaerobic processes [35]. Moreover, in children approximately 40%
of energy production in the WanT test comes from aerobic metabolism [30]. In
addition, although an incremental exercise test explores aerobic capacity and is
not a valid tool for assessing anaerobic performance [36], the increase in serum
lactate values seen in TG suggests a larger contribution of anaerobic glycolysis
during peak aerobic exercise. In other words, improved anaerobic energy metab-
olism possibly enhanced aerobic power output. This is supported by the finding
that during specific aerobic training a decrease is seen in serum lactate concen-
tration [37].
Increased anaerobic performance has been linked to biochemical
changes in muscle of children [31]. Fournier and colleagues reported a 21%
increase in anaerobic enzyme activity after sprint training [31]. Subsequently,
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higher serum lactate values in our study provides indirect evidence in support of
improvements in biochemical processes associated with anaerobic metabolism
as a result of the training program. 
Improvements in HRQL, as measured by the disease-specific Cystic
Fibrosis Questionnaire, were seen in TG. This is consistent with the results other
studies who found improvements in quality of life scores after aerobic training
as measured with a generic measure (Quality of Well-Being Scale) [5,38].
Furthermore, as shown in our study and in other studies [5,38], changes in HRQL
are related to changes in exercise performance. This emphasizes the need to fur-
ther assess both HRQL and exercise performance which provides valuable infor-
mation on the multidimensional impact of the disease on patient’s quality of life
and can make an important contribution to decision making in clinical practice [38,39]. 
In our study no positive or adverse effects were seen in pulmonary func-
tion, FFM and peripheral muscle strength due to the training program. As could
be expected, no change was found in the amount of habitual physical activity,
since we asked the participants not to change their activity level during the study
period. Until now, the influence of physical training on pulmonary function has
not been clearly established. Several studies showed improvements in pul-
monary function after aerobic training [40-42]. In contrast, other studies failed to
detect improvements in pulmonary function [1,2,38,43]. Eventually, all studies
show that training is safe for the patients’ respiratory condition.
Effects of follow-up period
The increases found in the study parameters in TG decreased to baseline value
after the 12-week follow-up period with the exception of anaerobic performance
and HRQL. Generally, benefits of exercise disappear if physical activity is dis-
continued. However, as shown in our study and studies of others [38,41] benefits
due to training seem to continue for some time in patients with CF, regardless
of follow-up training sessions. 
Clinical implications of anaerobic training
Up to now, anaerobic exercise has received little attention compared to aerobic
exercise, although many activities in daily life as well as sport activities are both
aerobic and anaerobic in nature [8,9]. Regular exercise is an important part of
treatment in CF. Adherence to exercise programs depends on individual moti-
vation and variation in activities. The children enjoyed our training program,
which motivated them to attend 98% of the training sessions. Our anaerobic
training program offered the necessary variation to enhance its adherence. The
increase in anaerobic and aerobic performance and in HRQL after anaerobic
training indicates that this type of training can be included in the overall physi-
cal rehabilitation of children with mild to moderate CF. Ideally, an exercise pro-
gram for children with CF could be made of aerobic, anaerobic and strength-
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training activities. This makes it possible to individual tailor the program accord-
ing to the preference of the participants, thereby improving levels of exercise
adherence [44]. 
In conclusion, our results suggest that children with mild to moderate
CF can enhance their anaerobic and aerobic performance and HRQL through
participation in a structured anaerobic exercise training program. In addition,
aerobic performance increases as well. The improvements in anaerobic per-
formance and HRQL are maintained through a 12-week follow-up period.
Therefore, anaerobic training could be an important component of the rehabili-
tation program of children with CF.
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General Discussion
7
Peter Klijn 
Introduction
In this chapter, a general discussion is presented based on the studies reported
in this thesis. In addition, some issues that have not been addressed in the pre-
vious chapters, and might give more insight in the direction of future studies,
will be discussed.
Aerobic and anaerobic metabolism
An important aim of this thesis was to investigate the influence of CF on anaer-
obic exercise performance of children. So far, research has focussed on aerobic
exercise performance. As stated in the introduction, this is somewhat surprising
since children’s natural activity pattern is characterized by anaerobic activities
(figure 3). However, aerobic fitness is associated with prolonged survival and
quality of life, and regular aerobic exercise has positive effects on the aerobic
exercise capacity of patients with CF [1-5]. Until now, the effects of CF on aerobic
fitness in children have only been described in cross sectional studies. In chap-
ter 2 we demonstrated that longitudinal changes in pulmonary function are asso-
ciated with changes in aerobic exercise capacity in children with CF and mild pul-
monary disease. Over a two-year period a decrease was found in age and gender
predicted values of pulmonary function and VO2peak. In the introduction, a
description was given on the close relationship between aerobic and anaerobic
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Figure 1  
Hypothesised change in aerobic and anaerobic fitness with disease progression
energy metabolism. In CF, as in other pulmonary diseases like chronic obstruc-
tive pulmonary disease (COPD) and asthma, a shift from aerobic to anaerobic
energy production as a resultant of disease progression, is thought to be an
important factor in maintaining exercise performance [6-8]. Generally, anaerobic
energy production does not depend on the lung’s ability to exchange gas but on
the amount of fat-free mass (FFM; i.e. muscle mass). Therefor, anaerobic exer-
cise performance should be independent of pulmonary dysfunction. However,
until now the relationship between pulmonary function and anaerobic perform-
ance has not been clearly established in children with CF.  In chapter 3 we
showed that children with CF and moderate pulmonary dysfunction had better
anaerobic exercise capacity at equivalent FFM, but lower predicted aerobic exer-
cise capacity compared to children with mild pulmonary dysfunction. 
Decrease in aerobic capacity is already seen in young children with mild
pulmonary disease, which on the long-term might lead to enhanced anaerobic
energy metabolism with progression of pulmonary disease. So, from these stud-
ies we hypothesise that in children with CF and progressive lung disease, the
decline of aerobic exercise performance is compensated by increase of anaero-
bic exercise performance. This can be a mechanism to maintain physical fitness
for a prolonged period (see Figure 1).
More evidence that is direct and possible explanations for a compensa-
tory mechanism needs to be studied. In children, non-invasive methods like
phosphorus-31 nuclear magnetic resonance (31P-NMR) measurements are to be
preferred. It would be interesting to study whether intrinsic abnormalities of
skeletal muscle and defects in the synthesis of ATP are present in pediatric CF
muscle during high intensity anaerobic work using a NMR spectrometer as has
been shown for aerobic work in children with CF. In addition, further studies are
indicated to investigate the combined long-term changes in aerobic and anaero-
bic exercise performance of children with CF in the full range of illness severity.
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Body composition
Another matter that needs further comment is the use of indices of nutritional sta-
tus and body composition in relation to exercise performance and disease severi-
ty. Nutritional status and body composition are often used together and some-
times considered as synonymous. BMI is widely used in pediatric research for eval-
uating nutritional status or body composition, owing to the relative ease with
which the measurements can be done. However, BMI is highly correlated with FM
and FFM but can not distinguish either of them. Therefore, BMI is at best seen as
an abstract index of nutritional status rather than as a measure of body composi-
tion [9]. The studies described in chapter 2 and 3 demonstrated that FFM was an
important predictor of aerobic and anaerobic exercise capacity. However, as stated
in chapter 2, age and gender predicted values for pediatric FFM proportions are
missing. These are especially important since CF has adverse effects on fat mass
and fat-free mass, causing changes in body composition. A complicating factor is
that due to growth and maturation FFM increases with age. However, the statural
growth and the increase in FFM and FM are slower in young children with CF com-
pared to healthy controls [10]. In addition, the adolescent growth spurt, which is an
important phase in the deposition of FM and FFM, is delayed by about a year in
CF [11]. These are all sources of variation in the evaluation of body composition in
relation to exercise performance in children with CF. Therefore, reference values for
pediatric FFM proportions should not only be based on gender and chronological
age, but also on biological age (biological maturity).
Biometric modeling
The separation and quantification of the independent contribution of disease
severity to aerobic and anaerobic exercise performance lies upon the appropriate
removal of the effects of FFM. Traditionally, ratio standards are used to facilitate
comparisons between individuals of different body-size (e.g. PP per kg FFM; VO2
per kg body weight). The resulting scaled physiological performance variables are
assumed to be independent of the individuals body-size dimension [12]. However,
ratio standards are theoretically not correct as was already shown by Tanner in
1949 [13]. Ratio standards imply that every kilogram FFM or body weight is associ-
ated with a specific amount of power (W) or oxygen uptake. In recent years more
research has focussed on the use of allometric or power function models in the
healthy population. The power function assumes the following model between the
physiological variable (Y) and the body size variable (X) [14]:
Y = a · Xb
When scaling or normalizing physiological measurements for differences in body
size, Nevill and colleagues proposed the power function ratio (Y/Xb), derived from
the allometric model that would render the subject’s physiological performance
variable (Y) independent of their body size variable (X) [12].   
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The power function model was applied to the anaerobic and FFM data from chapter 3.
No differences were found between the power function of the mild group (FEV1 ≥ 80 %)
and the moderate group (FEV1 < 80 %). Hence, a common power function was derived:
PP = 4.18 · FFM1.44 (figure 2)
The appropriate method of scaling should be the power function ratio standard:
PP/FFM1.44
The correlation between the simple ratio standard, PP (W/kg FFM), and FFM
(kg) was r = 0.47 (p<0.01), i.e. the simple ratio standard failed to produce a size
independent physiological performance variable. In contrast, when PP was
scaled according to the power function method (PP/FFM1.44) and correlated
with FFM (kg) the correlation was found to be zero (r = 0.01, p=0.906). Hence,
the scaled physiological variable was independent of the body size dimension. 
With respect to disease severity, table 1 shows correlations between absolute
PP, PP adjusted for FFM and BW (simple ratio standard) and PP adjusted for FFM
(power function ratio standard). The results indicate that when the appropriately scaling
method is used, PP adjusted for FFM is significantly correlated with all pulmonary func-
tion measures. This result strongly underlines the results found in chapter 3.
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Figure 2  
The power functional relationship between peak power and fat-free mass
Table 1   Correlation between pulmonary function and absolute and relative peak power
FEV1 %pred VC %pred RV/TLC % FEF25-75 %pred
PP (W) -0.05 0.07 -0.02 -0.14
PP (W/kg BW) -0.08 -0.03 0.04 -0.16
PP (W/kg FFM) -0.32* -0.16 0.27 -0.40**
PP (W/ kg FFM1.44) -0.49** -0.33* 0.48** -0.53***
PP = peak power; BW = body weight; FFM = fat-free mass; FEV1 = forced expiratory volume in one second; VC =
vital capacity; RV = residual volume; TLC = total lung capacity; FEF25-75: forced expiratory flow at 25-75% of VC. 
*p<0.05, ** p<0.01, *** p<0.001
Multi-level modeling is a another comparatively new and complex biometric method,
but it provides a valuable adjustment to existing analytical techniques used in physi-
ology of exercise and to longitudinal studies that investigate the physiological devel-
opment from childhood through adolescence to adulthood [15]. Multi-level modeling
is a form of multiple regression that can analyze hierarchically structured data. In lon-
gitudinal data, a hierarchy is set at two levels: level 1 and level 2. Level 1 comprises the
repeated measurement occasions and level 2 comprises the individual [16]. For exam-
ple, individuals have their own rates of growth that might vary randomly in compari-
son with the mean response of the group (level 1). Similarly, each individual’s meas-
urement might vary around their growth trajectory (level 2). An advantage of multi-
level modeling compared to traditional methods is that data sets do not have to be
complete from occasion to occasion and the time intervals between measurements
do not have to be equal for each individual. The interested reader is referred to the
work of Goldstein [17,18].
Multi-level modeling has only recently been applied to sport and exercise sci-
ence. It is promising to see that published studies have demonstrated the utility of the
technique, especially where the effects of growth, development, gender and exercise
training have to be disentangled [19-24]. The group of Neil Armstrong and Joanne
Welsman in Exeter, United Kingdom have done a lot of interesting research in this area
[19,25-30]. It is important to note that increasingly more books on exercise physiology
include chapters or paragraphs on the use of scaling factors and multi-level modeling
[31-33]. 
Quality of life
With respect to quality of life, we validated the three CFQ questionnaires (i.e. CFQ-C,
CFQ-P, CFQ-14+). In chapter 4 and 5 it was stated that data are needed on the respon-
siveness of the CFQ. In chapter 6 it was shown that the CFQ-C and CFQ-14+ were able
to detect changes brought about by the training intervention. Although numbers are
small and the study was not designed to test the responsiveness of the CFQ-C and
CFQ-14+, this result adds to the validation of the CFQ questionnaires. 
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The standardized response mean (SRM i.e. the ratio of change in mean scores to the
standard deviation of the change) was calculated to assess the relative magnitude of
observed changes. SRM is interpreted using criteria described by Cohen: 0.2 repre-
sents a small change; 0.5 a moderate change and changes of 0.8 or higher are inter-
preted as a large change. Over the training period a large change of 1.10 was found for
the Physical Functioning domain. However, the minimal important clinical difference
should be determined in order to define the meaning of the HRQL changes
found in chapter 6.
This was the first study to document an improvement in the subjective judge-
ment of children with CF about their physical functioning after an anaerobic training
intervention. So far, changes in quality of life have only been related to changes in aer-
obic capacity [34]. However, this emphasizes the need to perform aerobic and/or
anaerobic exercise tests in children with CF, since it reflects the overall impact of the
disease on the patient’s quality of life.
Anaerobic exercise testing
Some remarks should also be made on the use of the anaerobic exercise test, the
Wingate test (WanT). The WanT is by far the most popular anaerobic test [35].
However, no objective criteria have been established to judge whether a ‘true’ maximal
workload has been reached. In order to obtain maximal power output it is essential to
match the external load to the capability of the active muscles. Optimization of resist-
ance setting is a disadvantage of the WanT. The main problem of using body weight
to predict anaerobic performance, is that the relationship between body weight and leg
function varies due to growth and maturation [36]. In addition, because of the test
duration, the WanT has a considerable aerobic component [7].
An alternative test, which is thought to be a more specific anaerobic test is
the force-velocity test (F-V test). The test consists of several (5 to 8) “all-out” 5 – 7 sec-
onds cycling bouts, each performed against a different, but constant, braking force.
Force-velocity and power-velocity functions are established and the resulting parabola
enables calculation, by interpolation, of PP for each subject, as well as the force that is
needed to achieve PP [36]. PP achieved by the F-V test is thought to be closer to a per-
son’s ‘true’ peak cycling power than measured by the WanT [37]. However, Van Praagh
and colleagues showed a high correlation (r = 0.93) between PP obtained by the F-V
test and PP obtained by the WanT, suggesting that both tests measure the same fac-
tor [38]. A disadvantage of the F-V test is the total time required (30 to 40 minutes) to
complete the test protocol. In comparison, the WanT takes about 15 minutes to com-
plete. Since aerobic and anaerobic energy metabolism are inextricably linked during
exercise, and the WanT covers a larger range of the anaerobic metabolism, the WanT
seems relatively favored in determining the effects of anaerobic training.
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Anaerobic training
To our knowledge, this was the first intervention study in children with CF that used
anaerobic training.  We showed that children with CF are able to improve their anaer-
obic and aerobic exercise performance, and HRQL due to a specific anaerobic training
program. In addition, the anaerobic training effect and the effect on HRQL was, in part,
maintained after a 12-week follow-up period. Moreover, VO2peak remained stable in the
training group over the 6-month study period. Selvadurai and colleagues showed that
benefits due to aerobic training continue for some time in patients with CF, regardless
of follow-up training sessions [34]. Including anaerobic training is likely to improve
adherence to exercise training due to larger variation in training activities. Therefore,
further studies are indicated to investigate the long-term effects of combined aerobic
and anaerobic training studies. Training sessions of approximately 8 weeks, every six
months might effectively improve long-term clinical outcome in children with CF.
Moreover, these “booster” sessions are possibly an attractive alternative for patients
who have poor adherence to life-long exercise regimes. Selvadurai and colleagues
showed that resistance-training is safe and clinically effective for children with CF,
thereby increasing the possibilities of composing exercise programs for children with
CF [34]. In order to create a coherent and motivating training network for children with
CF, physical education teachers could, next to physical therapy, organize extracurricu-
lar sport and exercise classes. 
Main conclusions
Exercise benefits in CF can be obtained from a wide variety of activities and from dif-
ferent training modalities (e.g. aerobic, anaerobic and strength). Training guidelines
should be followed, but most importantly, exercise programs should be primarily
based on the preference of the individual child! Including specialists, like physical edu-
cation teachers and exercise physiologists, could be of great value in designing exer-
cise programs in clinical practice.
Moreover, more work needs to be done before we fully understand the opti-
mal training guidelines and the role of physical exercise in the life of healthy children
and in those suffering from chronic diseases like CF. 
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In chapter 1 an introduction on general characteristics of cystic fibrosis (CF) is
provided, followed by an overview of literature on exercise studies in children
with CF. This literature review showed that children with CF are able to improve
their aerobic capacity with short-term training programs. While their pulmonary
function did not improve. Furthermore, an outline for anaerobic training in chil-
dren with CF is presented. Improvement of anaerobic performance is thought to
positively influence participation in daily activities as well as sport activities,
which may eventually lead to improvements of health-related quality of life.
Chapter 2 describes the longitudinal relationship between changes in
peak aerobic performance (VO2peak), pulmonary function and fat-free mass
(FFM) in sixty-five children with mild to moderate CF. It was concluded that
changes in VO2peak are associated with changes in pulmonary function and to
a lesser degree with changes in fat-free mass.
In chapter 3 the determinants of anaerobic performance are described
in thirty-nine children with mild to moderate CF. FFM was found the most
important determinant of anaerobic performance. In addition, pulmonary func-
tion also contributed significantly to anaerobic performance when FFM was con-
trolled for. An interesting outcome was that subjects with moderate pulmonary
dysfunction had higher anaerobic power output per FFM than subjects with mild
pulmonary dysfunction. It was suggested that anaerobic energy metabolism may
be enhanced with progression of pulmonary disease. 
Chapter 4 describes the validation process of the Cystic Fibrosis
Questionnaire (CFQ) for children with CF in the age from 6 to 13 years (CFQ-C)
and their parents (CFQ-P), and chapter 5 describes the validation process of the
CFQ for adolescents and adults (CFQ-14+). Although minor revisions are need-
ed, all three questionnaires showed adequate validity and reliability. It was con-
cluded that, the CFQ questionnaires can be used to monitor the health status
and quality of life of patients with CF from the age of 6 years throughout adult-
hood. 
Summary
Chapter 6 describes the effects of our anaerobic training program on aerobic and
anaerobic exercise performance, pulmonary function, fat-free mass, peripheral
muscle force and health-related quality of life. In the training group significant
positive effects were found for aerobic and anaerobic performance and for
health-related quality of life. It was concluded that anaerobic training could be an
important component of the physical rehabilitation program of children with CF.
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In hoofdstuk 1 wordt een inleiding gegeven over de aandoening cystic fibrosis
(CF, taaislijmziekte). Achtereenvolgens worden besproken de incidentie en mor-
taliteit, pathogenese en diagnose, en de pathofysiologie bij CF. 
Daarnaast wordt aan de hand van een literatuuroverzicht aandacht
besteed aan de rol van fysieke training bij kinderen met CF. De geselecteerde
trainingsstudies worden kort besproken wat betreft effecten op longfunctie,
functionele status (aëroob uithoudingsvermogen en spierkracht) en kwaliteit
van leven. Uit dit deel kan worden geconcludeerd dat kinderen met CF in staat
zijn om hun aërobe fitheid te vergroten door deelname aan een kortdurend
aëroob trainingsprogramma. De longfunctie verbeterd niet ten gevolge van een
trainingsprogramma, daarentegen lijkt lichamelijke inspanning wel van invloed
op het vertragen van de achteruitgang van de longfunctie. Daarnaast lijkt kracht-
training een goede aanvulling op de bestaande trainingsprogramma’s.
In het resterende deel van hoofdstuk 1 wordt een onderbouwing
gegeven voor het inzetten van anaërobe training bij kinderen met CF. Activiteiten
in het dagelijks leven, evenals veel sport- en spelactiviteiten zijn niet alleen
aëroob van aard, maar hebben ook een grote anaërobe component. In het
dagelijks leven komt het regelmatig voor dat kinderen een anaërobe inspanning
moeten leveren (bijvoorbeeld traplopen, een sprintje trekken). Het anaëroob
metabolisme zou meer gerelateerd zijn aan de activiteiten in het dagelijks leven
dan het aëroob metabolisme. Diverse studies hebben aangetoond dat het
anaërobe prestatievermogen van kinderen met CF lager is in vergelijking met
gezonde leeftijdgenoten. Bovendien nemen kinderen met CF minder deel aan
activiteiten met een hoge intensiteit (grote anaërobe component). Door gerichte
anaërobe training zou de kwaliteit van leven van kinderen met CF kunnen ver-
beteren doordat zij makkelijker kunnen deelnemen aan allerlei bewegings-
activiteiten. 
In hoofdstuk 2 van dit proefschrift worden de resultaten beschreven van
een twee-jarige longitudinale studie. Doel was om de lange termijn relatie tussen
veranderingen in de aërobe fitheid, longfunctie en lichaamssamenstelling te
bepalen bij 65 kinderen met CF in de leeftijd van 4 tot 18 jaar. Het aëroob inspan-
ningsvermogen werd gemeten met een maximale inspanningstest op de
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loopband door kinderen tot 12 jaar en op fietsergometer door kinderen vanaf 12
jaar. Geconcludeerd wordt dat longitudinale veranderingen in de piek zuurstof-
opname geassocieerd zijn met veranderingen in de longfunctie en in mindere
mate met veranderingen in de vetvrije massa. Fysieke training en voedingsinter-
venties lijken belangrijk bij de klinische prognose op lange termijn.
In hoofdstuk 3 is gekeken naar determinanten van het anaërobe inspan-
ningsvermogen bij 39 kinderen met mild tot matig CF in de leeftijd van 9 tot 17
jaar. Vetvrije massa, longfunctie, perifere spierkracht, en aëroob en anaëroob
inspanningsvermogen werden bepaald. De perifere spierkracht werd gemeten
met een ‘handheld’ dynamometer. Het aëroob en anaëroob inspanningsvermo-
gen werden bepaald op een fietsergometer respectievelijk met een maximale
inspanningstest en de Wingate test. De Wingate test is een maximale anaërobe
sprinttest met een duur van 30 seconden. De resultaten laten zien dat de vetvrije
massa de belangrijkste determinant is van het anaëroob inspanningsvermogen.
Een opvallende bevinding is dat bij een gelijke hoeveelheid vetvrije massa,
kinderen met een milde longfunctiestoornis een lagere score behalen op de
Winagte test dan kinderen met een matige longfunctiestoornis. Daarentegen
heeft laatst genoemde groep een significant grotere daling van de zuurstofsatu-
ratie tijdens de maximale aërobe inspanningstest. Deze resulaten suggereren
dat met een toename van de ernst van de longfunctiestoornis de achteruitgang
van de aërobe fitheid mogelijk gecompenseerd wordt door het anaërobe
energiemetabolisme.
In hoofdstuk 4 wordt de validatie en het bepalen van de betrouw-
baarheid beschreven van een ziekte-specifieke kwaliteit van leven vragenlijst, de
Cystic Fibrosis Questionnaire voor kinderen met CF (CFQ-C) en hun ouders
(CFQ-P). De CFQ-C bestaat uit 35 items verdeeld over 6 domeinen en 2 symp-
toomschalen. De CFQ-C wordt gebruikt bij kinderen in de leeftijd van 6 tot en
met 13 jaar. De CFQ-P bestaat uit 43 items verdeeld over zeven domeinen, drie
symptoomschalen en één gezondheidsschaal. Bij 68 kinderen en hun ouders
werden de CFQ lijsten afgenomen. De resultaten laten zien dat de CFQ-C en de
CFQ-P valide en betrouwbare lijsten zijn voor het meten van gezondheids-
gerelateerde kwaliteit van leven bij kinderen met CF en hun ouders.
In hoofdstuk 5 wordt de validatie van de CFQ voor adolescenten en vol-
wassenen (CFQ-14+) uit een gezet. De CFQ-14+ wordt gebruikt voor patienten
met CF vanaf 14 jaar. De CFQ-14+ bestaat uit 47 items verdeeld over negen
domeinen, drie symptoomschalen en één gezondheidsschaal. Uit het onderzoek
kan geconcludeerd worden dat de CFQ-14+ een valide instrument is voor het
meten van gezondheigsgerelateerde kwaliteit van leven bij adolescenten en vol-
wassenen met CF. Tezamen maken de CFQ-C en de CFQ-14+ het mogelijk om
de kwaliteit van leven en de gezondheidstoestand van patienten met CF vanaf
6 jaar te vervolgen.
In hoofdstuk 6 zijn de effecten van een anaëroob trainingsprogramma
voor kinderen met CF beschreven. Twintig kinderen met CF in de leeftijd tussen
10 en 17 jaar werden gerandomiseerd in een trainingsgroep (n=11) en in een
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controle groep (n=9). De kinderen in de trainingsgroep trainden tweemaal per
week, gedurende twaalf weken onder begeleiding van een geïnstrueerde
(kinder)fysiotherapeut of oefentherapeut. De trainingen vonden plaats in de
eigen woonplaats van de kinderen. 
In de trainingsgroep zijn significant positieve effecten gevonden op het
aëroob en anaëroob inspanningsvermogen. Bovendien is een significante toe-
name gevonden op het domein van Fysiek Functioneren van de CFQ-C en CFQ-
14+. Bij de controle groep zijn geen veranderingen gevonden op deze parame-
ters. Ook de longfunctie, de spierkracht en de vetvrije massa bleven onveranderd
in beide groepen.
Na een follow-up periode van twaalf weken bleek dat in de trainings-
groep het anaëroob inspanningsvermogen en de kwaliteit van leven nog steeds
significant hoger waren dan bij aanvang van het trainingsprogramma. 
Uit dit onderzoek kan geconcludeerd worden dat anaërobe training bij
kinderen met CF leidt tot een verbetering van de aërobe en anaërobe fitheid en
van de gezondheidsgerelateerde kwaliteit van leven. Daarnaast is het van belang
om vast te stellen dat de effecten van dit anaëroob trainingsprogramma deels
behouden blijven na een periode van twaalf weken, waarin geen formele training
heeft plaatsgevonden.
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Een twee, een twee, daar kwam Haas aangerend.
Hij was aan het joggen in de sneeuw.
'Hoi,' riep hij vrolijk, 'sport is gezond!
Doe mee, Kikkertje, beweging is goed voor je.'
Max Velthuis | Kikker in de kou | 1999
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Ruim 2,5 jaar geleden ben ik begonnen aan het avontuur dat nu ten einde is.
Velen hebben bijgedragen aan de tot standkoming van dit proefschrift.
Dank daarvoor. 
Ik wil een aantal mensen in het bijzonder noemen.
Allereerst wil ik alle kinderen en hun ouders bedanken voor het deelnemen aan
de vele onderzoeken die nodig waren om dit proefschrift te vullen!
Dr CK van der Ent, beste Kors, ik heb met heel veel plezier op jouw afdeling
rondgelopen. In een sfeer van professionaliteit én gezelligheid is het prettig
toeven. In deze sfeer heb je mij ook begeleid. Je kennis en kunde, je humor en
relativeringsvermogen waren een geweldige voedingsbodem bij mijn opleiding
tot onderzoeker. Heel veel dank daarvoor.
Dr J van der Net, beste Janjaap, jouw enorme inzet heeft ertoe bijgedragen dat
ondanks alle tegenslagen het toch gelukt is om dit promotietraject binnen de
gestelde tijd af te ronden. Je deur stond altijd open om even met mij van
gedachten te wisselen. Je professionaliteit, creativiteit en enthousiasme zijn zeer
bepalend geweest bij de tot standkoming van dit proefschrift. Het was een genot
om met je te werken. Heel veel dank daarvoor.
Dr VAM Gulmans, beste Vincent, het project is bij jou gestart. Onze wegen kruis-
ten elkaar op Heideheuvel en dat was het begin van een mooie samenwerking.
Het vertrouwen dat jij mij hebt gegeven en de wijze waarop je mij hebt begeleid
was heel bijzonder! Heel veel dank daarvoor. Zonder iemand tekort te willen
doen blijf ik het jammer vinden dat je het WKZ hebt verlaten.
Rink Kaashoek en Paul Heus, beste Rink en Paul, de felle discussies hebben
uiteindelijk geleid tot opnieuw een prachtig trainingsprogramma. Jullie zijn voor
mij de bevestiging dat sportleraren ‘key players’ zijn bij het maken van beweg-
ingsprogramma’s voor kinderen! Ik hoop in de toekomst nog vaker een beroep
Dankwoord
op jullie te mogen doen. Dank voor jullie vriendschap. Rink, ik vind het geweldig
dat je mijn paranimf wilt zijn.
Drs A Oudshoorn, lieve Annemarie, mijn onderzoeksmaatje vanaf dag één. Ik
vond het ontzettend leuk om met jou te mogen samenwerken. De Myovive
studie hebben we als een geoliede machine volbracht en toch hadden we nog tijd
over voor gezelligheid. Ontzettend bedankt. 
Ik heb heel veel bewondering voor de wijze waarop je je eigen project draaiende
houdt en ik ben er zeker van dat ook jij straks je ‘s’ mag inleveren.
Drs SWJ Terheggen-Lagro, lieve Suzanne de wijze waarop jij de kinderen voor het
prikken gerust wist te stellen was heerlijk om te zien. Daarbij was het prikje altijd
in één keer raak. Je kreeg niet voor niets de bijnaam ‘Barney’. Dit heeft zeker een
positieve invloed gehad op de kinderen als ze weer eens heel hard moesten fiet-
sen. Ook aan de tijd in Stockholm denk ik met heel veel plezier terug. Dancing
queen, ontzettend bedankt.
Dr JWH Custers, beste Jan, jij had misschien niet de meest dankbare taak na het
vertrek van Vincent, maar ik ben blij dat je deze taak toch op je hebt genomen.
Dank voor je inzet en enthousiasme.
Prof Dr PJM Helders, beste Paul, dank voor de mogelijkheid om op jouw afdel-
ing onderzoek te mogen doen. Mede door de profesionaliteit en de
deskundigheid van de collega’s, heb ik met veel plezier onderzoek gedaan op de
afdeling Kinderfysiotherapie. Mijn promotietraject verliep niet helemaal vlekken-
loos. Op de juiste momenten heb jij op een  karateristieke wijze de koe bij de
horens gevat, waardoor het project voort kon gaan. 
Prof Dr JLL Kimpen, beste Jan, dank voor je bereidheid om het promotorschap
op je te nemen en voor je bijdrage aan het tot stand komen van mijn proefschrift.
Je persoonlijke ‘touch’ heb ik zeer gewaardeerd. Ik vind het verheugend om te
zien dat de inspanningsfysiologie een aparte plek heeft gekregen binnen de
Divisie Kinderen.
Drs J van der Laag, Dr HGM Arets en Drs WAF Balemans, beste Han, Bert en
Walter, ook jullie wil bedanken voor jullie steun, hulp en belangstelling. Bij
afwezigheid van de vaste dokter, waren jullie altijd bereid om even in te springen
als er weer eens geprikt moest worden.
De afdeling kinderfysiotherapie, Dr Raoul Engelbert, Drs Ron van Empelen,
Marja Schoenmakers, Sonja Raaff, Carla van Rooyen, Annemieke Apeldoorn,
Rian Eysermans, Drs Ingelot van Haastert, Drs Femke Kooymans. Ontzettend
bedankt voor de zeer plezierige samenwerking, jullie steun en belangstelling. 
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Dr T Takken, beste Tim, beste paranimf, ik vond het heel plezierig om met jou
een kamer te delen. Je parate kennis is bijzonder en je visie verfrissend. Ik hoop
dat we ook in de toekomst op een aantal terreinen kunnen samenwerken.
De afdeling kinderlongziekten. Heel veel dank aan de longfunctieassistenten
voor de metingen en de leuke begeleiding van de kinderen: Wim Klein
Nagelvoort, Mariska Stehouwer-De Gooijer en Joyce Tersmette, en natuurlijk,
Ingeborg Prins voor net dat beetje extra…
Natuurlijk ook het secretariaat: Myriam en Sylvia , ontzettend bedankt
voor jullie steun, hulp en warme belangstelling, en Tineke, je bent geweldig. 
Langs deze weg wil ik ook alle (kinder)fysiotherapeuten en oefentherapeuten
hartelijk bedanken voor het deelnemen aan het trainingsonderzoek.
De leden van de beoordelingscommissie, Prof Dr W Kuis, Prof Dr AJ van Vught,
Prof Dr R Berger, Prof Dr J-WJ Lammers en Dr ML Zonderland, dank voor de kri-
tische beoordeling van het manuscript.
Dr C van der Schans, Dr M Nieuwenhuis, W Doeleman, Dr J Gerritsen, bedankt
voor jullie bijdrage aan de CFQ artikelen.
Prof  Dr A Quittner, dear Alexandra, thank you for meeting with the
Dutch CFQ workgroup in New Orleans. Your comments and suggestions have
led to major improvements of the CFQ manuscripts. 
Roche Nederland B.V. in de persoon van Drs J Los, beste Job, bedankt voor de
mogelijkheid om de CFQ op te nemen in mijn proefschrift en ik hoop dat onze
verdere samenwerking leidt tot een succesvolle implementatie van de CFQ. Ik
kijk met veel plezier terug op de orkaan van New Orleans!
Miranda Thoonen, lieve Miranda, ik vind het heel leuk dat je de opmaak van mijn
proefschrift hebt willen doen. Het resultaat is prachtig!
Ook op Heideheuvel wil ik iedereen bedanken voor de warme belangstelling.
Er zijn een aantal mensen die ik in het bijzonder wil noemen. 
Prof  Dr JM Bogaard, beste Jan, ik heb het zeer gewaardeerd dat je mij
tijdens mijn pre-WKZ jaren hebt geholpen met het opzetten van onderzoek bin-
nen Heideheuvel. Ik hoop in de nabije toekomst nog vaker een beroep op je te
mogen doen.
Drs J Meijs, Drs L Rijssenbeek, beste Jos en Lous, ook jullie wil ik
bedanken voor het vertrouwen en de mogelijkheid om onderzoek te doen op de
kinderafdeling Twee mooie bewegingsprogramma’s zijn het uiteindelijke resultaat.
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Dr HF van Stel, beste Henk, je kritische vragen en opmerkingen hebben de CFQ
artikelen mede vorm gegeven. Ik hoop ook in de toekomst nog veelvuldig van je
kennis, kunde en enthousiasme gebruik te mogen maken.
Jullie hebben er allemaal aan bijgedragen dat mijn wetenschappelijke
carriere niet vroegtijdig is beeindigd.
De (voormalige) vakgroep Bewegingstherapie, lieve Karin, Agnes, Hester,
Marieke, Hilde, lieve meisjes, jullie belangstelling en morele steun hebben de
promotiejaren gemakkelijker voor mij gemaakt. Jullie zijn een heerlijke groep en
ik hoop nog lang met jullie te mogen samenwerken.
Lieve mama en papa, jullie waren altijd bereid om op te passen of klusjes in huis
te doen als ik weer eens geen tijd had. Bedankt voor alles!
En tenslotte, 
Lieve Anika en Milena, papa ‘woont’ nu niet meer op de zolder en heeft nu weer
alle tijd voor jullie. De “tomtuter” is ook weer vrij om samen spelletjes op te spelen.
Ik zal niet meer zo vaak op onderzoek uit gaan.
Draga, draga Sanja, mijn allergrootste steun en vriendin gedurende de afgelopen
jaren. Zonder jou was het, ondanks de vele inspanningen van alle bovenge-
noemde personen, nooit gelukt!
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Peter Klijn werd geboren op 29 april 1964 te Mijdrecht. Nadat hij mavo, havo en
vwo achter zich had gelaten begon hij in 1984 zijn studie tot leraar lichamelijke
opvoeding aan de Academie voor Lichamelijke Opvoeding te Amsterdam. Na
het behalen van zijn akte L.O. studeerde hij vanaf 1988 studeerde aan de
Faculteit Bewegingswetenschappen van de Vrije Universiteit van Amsterdam. In
1992 studeerde hij af met als specialisaties inspanningsfysiologie en biochemie,
en als nevenspecialisatie psychologie met betrekking tot het menselijk bewegen. 
In 1993 heeft hij met zijn huidige vrouw Sanja een reis door Azie
gemaakt, waarna hij in 1994 neerstreek als bewegingstherapeut op astmacen-
trum Heideheuvel te Hilversum.
Hij is als co-auteur betrokken geweest bij het ‘Bewegingsprogramma
voor kinderen met astma’. In mei 2000 is hij begonnen aan het promotieproject
‘anaerobe training en kwaliteit van leven bij kinderen met Cystic Fibrosis’ op de
afdeling kinderfysiotherapie (hoofd: Prof  Dr PJM Helders) en de afdeling kinder-
longziekten (hoofd: Dr  CK van der Ent) van het Wilhelmina Kinderziekenhuis te
Utrecht. Naast zijn promotietraject heeft hij op astmacentrum Heideheuvel
onderzoek gedaan naar een bewegingsprogramma voor kinderen met obesitas
en een trainingsprogramma voor kinderen met astma. Vanaf februari 2003 werkt
hij als onderzoeker en bewegingstherapeut op astmacentrum Heideheuvel. 
Peter is getrouwd met Sanja Zivojnovic. Samen hebben zij twee
kinderen, Anika (1996) en Milena (1999).
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